|
|
|
|
|
|
|
|
|
|
| UPDATE: May 2009 | MW: 46.08 | MF: C2H6O |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
500 mg
|
severe
|
AJOPAA 29,1363,1946
|
eye | rabbit
500 mg/24 hour
|
mild
|
85JCAE -,189,1986
|
eye | rabbit
100 mg/4S rinse
|
moderate
|
FCTOD7 20,573,1982
|
skin | rabbit
400 mg open irritation test
|
mild
|
UCDS** 7/22/1970
|
skin | rabbit
20 mg/24 hour
|
moderate
|
85JCAE -,189,1986
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
parenteral | grasshopper
500 mmol/L
|
NATWAY 51,646,1964
|
cytogenetic analysis
|
hamster
ovary
|
100 ppm
|
ENMUDM 8(Suppl 6),72,1986
|
cytogenetic analysis
|
hamster
embryo
|
1 pph
|
MUTAEX 3,207,1988
|
cytogenetic analysis
|
hamster
ovary
|
160 mmol/L
|
BIZNAT 106,169,1987
|
cytogenetic analysis
|
human
lymphocyte
|
1,160 gm/L
|
AEMBAP 85A,25,1977
|
cytogenetic analysis
|
human
fibroblast
|
12,000 ppm
|
ACYTAN 16,41,1972
|
cytogenetic analysis
|
human
leukocyte
|
1 pph/72 hour- continuous
|
TSITAQ 20,421,1978
|
cytogenetic analysis
|
human
lymphocyte
|
2.5 pph/24 hour
|
MUREAV 537,117,2003
|
cytogenetic analysis
|
oral | human
49,014 gm/kg/25 year
|
MUREAV 560,187,2004
|
cytogenetic analysis
|
oral | mouse
40 gm/kg
|
NATUAS 302,258,1983
|
cytogenetic analysis
|
intramuscular | other fish
1 pph
|
MUREAV 542,1,2003
|
cytogenetic analysis
|
oral | rat
2 gm/kg
|
TGANAK 14(5),48,1980
|
dominant lethal test
|
oral | mouse
3,720 mg/kg/3 day
|
AEMBAP 85A,25,1977
|
DNA adduct
|
oral | rat
5 gm/kg
|
MUREAV 479,81,2001
|
DNA adduct
|
oral | rat
3 gm/kg/7 day
|
MUREAV 479,81,2001
|
DNA damage
|
oral | rat
4 gm/kg
|
MUREAV 345,191,1995
|
DNA damage
|
Salmonella typhimurium
|
15 pph/120 minute
|
MUREAV 575,34,2005
|
DNA damage
|
Saccharomyes cerevisiae
|
850 mmol/L
|
MUREAV 326,165,1995
|
DNA inhibition
|
human
lymphocyte
|
220 mmol/L
|
PNASA6 79,1171,1982
|
DNA repair
|
Escherichia coli
|
5 mg/well
|
MUREAV 133,161,1984
|
DNA repair
|
Salmonella typhimurium
|
15 pph/120 minute
|
MUREAV 575,34,2005
|
mutation in microorganisms
|
Aspergillus nidulans
|
20 pph (-enzymatic activation step)
|
MUREAV 48,51,1977
|
mutation in microorganisms
|
Escherichia coli
|
140 gm/L (-enzymatic activation step)
|
MUREAV 130,97,1984
|
mutation in microorganisms
|
Salmonella typhimurium
|
11 pph (+enzymatic activation step)
|
ENVRAL 52,225,1990
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
24 pph (-enzymatic activation step)
|
GNKAA5 15,927,1979
|
micronucleus test
|
dog
lymphocyte
|
400 µmol/L
|
NTIS** AD-A075-605
|
micronucleus test
|
human
liver
|
15 mmol/L/24 hour
|
TXCYAC 198,315,2004
|
micronucleus test
|
oral | human
817.6 gm/kg/6 year- intermittent
|
MUREAV 615,134,2007
|
micronucleus test
|
intraperitoneal | mouse
1,240 mg/kg/2 day
|
AEMBAP 85A,25,1977
|
micronucleus test
|
intramuscular | other fish
1 pph
|
MUREAV 542,1,2003
|
gene conversion and mitotic recombination
|
Aspergillus nidulans
|
5 pph
|
MUREAV 48,51,1977
|
other mutation test systems
|
intraperitoneal | rat
250 gm/kg/16 day- continuous
|
CYTBAI 56,195,1988
|
other mutation test systems
|
oral | rat
3 gm/kg
|
APTOA6 49,125,1981
|
sister chromatid exchange
|
hamster
ovary
|
3,900 mg/L
|
MUREAV 124,85,1983
|
sister chromatid exchange
|
human
lymphocyte
|
500 ppm/72 hour- continuous
|
CGCGBR 27,66,1980
|
sister chromatid exchange
|
oral | mouse
420 mg/kg/3 week
|
MUREAV 68,291,1979
|
sex chromosome loss and nondisjunction
|
Aspergillus nidulans
|
30 gm/L
|
EVHPAZ 31,81,1979
|
sex chromosome loss and nondisjunction
|
oral | Drosophila melanogaster
10 pph
|
MUREAV 268,95,1992
|
sex chromosome loss and nondisjunction
|
oral | mouse
5 gm/kg
|
CGCGBR 44,7,1987
|
specific locus test
|
oral | rat
56 gm/kg/4 week
|
MUREAV 577S,1,2005
|
sperm morphology
|
oral | mouse
1,500 mg/kg/50 day
|
MUREAV 65,229,1979
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intracerebral | rat
lowest published toxic dose: 5 mg/kg (1 day prior to copulation)
|
Reproductive: Effects on fertility: Other measures of fertility
|
JRPFA4 42,199,1975
|
inhalation | rat
lowest published toxic concentration: 20,000 ppm/7 hour (1-22 day pregnant)
|
Reproductive: Other developmental abnormalities
|
TJADAB 29(2),48A,1984
|
intraperitoneal | mouse
lowest published toxic dose: 5,800 mg/kg (10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TJADAB 27,231,1983
|
intraperitoneal | mouse
lowest published toxic dose: 5,800 mg/kg (7 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Eye, ear Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
TJADAB 27,231,1983
|
intraperitoneal | mouse
lowest published toxic dose: 5,622 µg/kg (10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Specific developmental abnormalities: Eye, ear Reproductive: Specific developmental abnormalities: Musculoskeletal system
AJOGAH 124,676,1976
|
intraperitoneal | mouse
lowest published toxic dose: 4 mg/kg (10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material)
|
ANREAK 193,515,1979
|
intraperitoneal | mouse
lowest published toxic dose: 4,300 mg/kg (10 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
NETOD7 2,227,1980
|
intraperitoneal | mouse
lowest published toxic dose: 2.9 gm/kg (8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material)
|
TOXID9 72,171,2003
|
intraperitoneal | mouse
lowest published toxic dose: 15 mg/kg (6-8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Other developmental abnormalities
REPTED 17,475,2003
|
intraperitoneal | mouse
lowest published toxic dose: 22.8 gm/kg (6-8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
REPTED 20,453,2005
|
intraperitoneal | mouse
lowest published toxic dose: 22.8 gm/kg (6-8 day pregnant)
|
Reproductive: Other effects to embryo or fetus | Reproductive: Specific developmental abnormalities: Eye, ear
REPTED 20,453,2005
|
intraperitoneal | mouse
lowest published toxic dose: 22.8 gm/kg (6-8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Other developmental abnormalities
REPTED 22,263,2006
|
intraperitoneal | mouse
lowest published toxic dose: 5.8 gm/kg (3-5 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
BDERE* 70,163,2004
|
intraperitoneal | mouse
lowest published toxic dose: 22.8 gm/kg (6-8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Eye, ear
JTEHF8 67,2073,2004
|
intraperitoneal | mouse
lowest published toxic dose: 2,900 mg/kg (8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TERP2* -,368,2005
|
intraperitoneal | mouse
lowest published toxic dose: 2,900 mg/kg (8 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
TERST* -,315,2006
|
intraperitoneal | mouse
lowest published toxic dose: 2,900 mg/kg (8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TERST* -,315,2006
|
intraperitoneal | rat
lowest published toxic dose: 15 gm/kg (8-13 day pregnant)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Physical
TJADAB 36,31A,1987
|
intraperitoneal | rat
lowest published toxic dose: 2,240 mg/kg (9-12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord)
|
DABBBA 38,5835,1978
|
intraperitoneal | rat
lowest published toxic dose: 600 mg/kg (8-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TJADAB 26(1),12A,1982
|
intraperitoneal | rat
lowest published toxic dose: 600 mg/kg (8-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
IJEBA6 21,108,1983
|
intraperitoneal | rat
lowest published toxic dose: 600 mg/kg (8-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
IJEBA6 21,108,1983
|
intraperitoneal | rat
lowest published toxic dose: 3,600 mg/kg (7-8 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
NELED5 289,13,2000
|
intraperitoneal | rat
lowest published toxic dose: 11.25 mg/kg (7-9 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Other developmental abnormalities
REPTED 17,475,2003
|
intraperitoneal | rat
lowest published toxic dose: 18,000 mg/kg (5-21 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Other postnatal measures or effects
BDERE* 73,897,2005
|
intratesticular | dog
lowest published toxic dose: 100 mg/kg (1 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
FESTAS 24,884,1973
|
intratesticular | rat
lowest published toxic dose: 400 mg/kg (1 day male)
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
|
FESTAS 24,884,1973
|
intrauterine | rat
lowest published toxic dose: 2,400 mg/kg (10 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
IJEBA6 14,316,1976
|
intrauterine | woman
lowest published toxic dose: 200 mg/kg (5 day prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated)
|
INJFA3 14,280,1969
|
intravenous | domestic animal
lowest published toxic dose: 94 gm/kg (14-21 week pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
PBBHAU 12,329,1980
|
intravenous | domestic animal
lowest published toxic dose: 40 gm/kg (14-17 week pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on newborn: Biochemical and metabolic
NTOTDY 3,105,1981
|
intravenous | domestic animal
lowest published toxic dose: 1 gm/kg (18 week pregnant)
|
Reproductive: Specific developmental abnormalities: Respiratory system
|
AJOGAH 151,859,1985
|
intravenous | domestic animal
lowest published toxic dose: 29,000 mg/kg (106-134 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Effects on newborn: Other neonatal measures or effects Reproductive: Effects on newborn: Behavioral
NETEEC 22,205,2000
|
intravenous | rat
lowest published toxic dose: 4 gm/kg (6-7 day pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) | Reproductive: Other effects to embryo or fetus Reproductive: Specific developmental abnormalities: Musculoskeletal system
RECYAR 8,105,1971
|
intravenous | rat
lowest published toxic dose: 3 gm/kg (6-7 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
RECYAR 8,105,1971
|
intravenous | rat
lowest published toxic dose: 4 gm/kg (6-7 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Other developmental abnormalities
RECYAR 8,105,1971
|
intravenous | rabbit
lowest published toxic dose: 15 mg/kg (15-29 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Other effects to embryo or fetus
JPDSA3 29,1030,1994
|
intravenous | woman
lowest published toxic dose: 8 gm/kg (32 week pregnant)
|
Reproductive: Effects on newborn: Apgar score (human only) | Reproductive: Effects on newborn: Other neonatal measures or effects
AJDCAI 134,419,1980
|
multiple | rat
lowest published toxic dose: 642 gm/kg (1-21 day pregnant/23 day after birth)
|
Reproductive: Maternal effects: Parturition | Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
DEPBA5 10,435,1977
|
multiple | rat
lowest published toxic dose: 373 gm/kg (23 day after birth)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Physical
DEPBA5 10,435,1977
|
oral | dog
lowest published toxic dose: 21,600 mg/kg (1-60 day pregnant)
|
Reproductive: Effects on newborn: Stillbirth | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
FEPRA7 36,285,1977
|
oral | dog
lowest published toxic dose: 260 gm/kg (1-62 day pregnant)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
|
ACRSDM 4,123,1980
|
oral | dog
lowest published toxic dose: 221 gm/kg (1-47 day pregnant)
|
Reproductive: Effects on fertility: Abortion
|
ACRSDM 4,123,1980
|
oral | guinea pig
lowest published toxic dose: 90 gm/kg (1-68 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Behavioral
ANREAK 127,438,1957
|
oral | guinea pig
lowest published toxic dose: 240 gm/kg (2-61 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Central nervous system
DBRRDB 106,39,1998
|
oral | guinea pig
lowest published toxic dose: 264 gm/kg (2-67 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Biochemical and metabolic Reproductive: Effects on newborn: Physical
ACRSDM 23,1816,1999
|
oral | guinea pig
lowest published toxic dose: 72 gm/kg (45-62 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
FAJOEC 14,A1447,2000
|
oral | guinea pig
lowest published toxic dose: 76,000 mg/kg (43-62 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Effects on newborn: Other neonatal measures or effects Reproductive: Other effects to embryo or fetus
NETEEC 23,355,2001
|
oral | guinea pig
lowest published toxic dose: 264,000 mg/kg (2-67 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Effects on newborn: Physical
NETEEC 22,183,2000
|
oral | guinea pig
lowest published toxic dose: 264 gm/kg (2-67 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic | Reproductive: Effects on newborn: Other postnatal measures or effects
NETEEC 25,59,2003
|
oral | guinea pig
lowest published toxic dose: 272 gm/kg (2-67 day pregnant)
|
Reproductive: Effects on newborn: Other postnatal measures or effects | Reproductive: Effects on newborn: Delayed effects
NETEEC 26,59,2004
|
oral | guinea pig
lowest published toxic dose: 57 gm/kg (43-62 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
NETEEC 26,543,2004
|
oral | guinea pig
lowest published toxic dose: 204 gm/kg (0-67 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Behavioral
JPETAB 308,650,2004
|
oral | guinea pig
lowest published toxic dose: 264 gm/kg (2-67 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on newborn: Behavioral
NETEEC 28,333,2006
|
oral | guinea pig
lowest published toxic dose: 260 gm/kg (2-67 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Effects on newborn: Behavioral
ALCOH* 41,577,2007
|
oral | mammal (species unspecified)
lowest published toxic dose: 31,500 mg/kg (15-35 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TJADAB 30,203,1984
|
oral | monkey
lowest published toxic dose: 78 gm/kg (4-23 week pregnant)
|
Reproductive: Effects on fertility: Abortion
|
TJADAB 35,345,1987
|
oral | monkey
lowest published toxic dose: 400 mg/kg (2-21 week pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
TJADAB 29,49,1984
|
oral | monkey
lowest published toxic dose: 206 gm/kg (90 day prior to copulation)
|
Reproductive: Maternal effects: Menstrual cycle changes or disorders
|
SCIEAS 221,677,1983
|
oral | monkey
lowest published toxic dose: 32,400 mg/kg (2-19 week pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Central nervous system Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
TJADAB 44,29,1991
|
oral | monkey
lowest published toxic dose: 43,200 mg/kg (1-24 week pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord)
|
TJADAB 44,29,1991
|
oral | mouse
lowest published toxic dose: 162 gm/kg (11-19 day pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord)
|
TJADAB 27,56A,1983
|
oral | mouse
lowest published toxic dose: 21 gm/kg (1-21 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic | Reproductive: Effects on newborn: Behavioral
JSALDP 38,1696,1977
|
oral | mouse
lowest published toxic dose: 5,800 mg/kg (7 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Eye, ear
TJADAB 27,231,1983
|
oral | mouse
lowest published toxic dose: 75,600 mg/kg (5-11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
RCOCB8 23,127,1979
|
oral | mouse
lowest published toxic dose: 5,500 mg/kg (9 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TJADAB 24(1),53A,1981
|
oral | mouse
lowest published toxic dose: 1,680 gm/kg (70 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
FEPRA7 39,542,1980
|
oral | mouse
lowest published toxic dose: 20 gm/kg (multigenerations)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
NTIS** #PB85118651
|
oral | mouse
lowest published toxic dose: 20 gm/kg (multigenerations)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
NTIS** #PB85118651
|
oral | mouse
lowest published toxic dose: 20 gm/kg (multigenerations)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
NTIS** #PB85118651
|
oral | mouse
lowest published toxic dose: 700 gm/kg (7 day male/7 day prior to copulation/21 day pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
|
NTIS** #PB85118651
|
oral | mouse
lowest published toxic dose: 60 gm/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
MUREAV 577S,1,2005
|
oral | mouse
lowest published toxic dose: 50 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death
REPTED 22,61,2006
|
oral | mouse
lowest published toxic dose: 50 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
REPTED 22,61,2006
|
oral | mouse
lowest published toxic dose: 3,270 gm/kg (13 week prior to copulation-3 week pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
BDERE* 73,980,2005
|
oral | mouse
lowest published toxic dose: 3,210 gm/kg (13 week prior to copulation-16 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
BDERE* 73,65,2005
|
oral | mouse
lowest published toxic dose: 360 gm/kg (60 day male/60 day prior to copulation)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
BDERB* 71,135,2004
|
oral | mouse
lowest published toxic dose: 180 gm/kg (60 day prior to copulation)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
BDERB* 71,135,2004
|
oral | mouse
lowest published toxic dose: 2,900 mg/kg (8 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TERMG* -,234,2003
|
oral | pig
lowest published toxic dose: 2,648 gm/kg (78 week prior to copulation/1-16 week pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
NTOTDY 5,229,1983
|
oral | rat
lowest published toxic dose: 78 gm/kg (7-19 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
PBBHAU 59,577,1998
|
oral | rat
lowest published toxic dose: 4 gm/kg (13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material)
|
CYGEDX 15(2),23,1981
|
oral | rat
lowest published toxic dose: 322 gm/kg (35 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct
INJFA3 23,176,1978
|
oral | rat
lowest published toxic dose: 12 gm/kg (9-12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
PLPSAX 7,311,1979
|
oral | rat
lowest published toxic dose: 132 gm/kg (1-22 day pregnant)
|
Reproductive: Maternal effects: Parturition | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Behavioral
TJADAB 23,217,1981
|
oral | rat
lowest published toxic dose: 24 gm/kg (14-16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Other developmental abnormalities
TJADAB 23,41A,1981
|
oral | rat
lowest published toxic dose: 354 gm/kg (10 day after birth)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
RCPBDC 2,119,1977
|
oral | rat
lowest published toxic dose: 4 gm/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Eye, ear | Reproductive: Specific developmental abnormalities: Urogenital system
JTEHD6 10,267,1982
|
oral | rat
lowest published toxic dose: 35,295 mg/kg (1-15 day pregnant)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
ONGZAC 22(1),71,1991
|
oral | rat
lowest published toxic dose: 44 gm/kg (7-17 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Urogenital system
ESKHA5 (103),10,1985
|
oral | rat
lowest published toxic dose: 191,220 mg/kg (2-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Behavioral Reproductive: Effects on newborn: Other postnatal measures or effects
NETEEC 23,453,2001
|
oral | rat
lowest published toxic dose: 30 gm/kg (1-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Other neonatal measures or effects
TJADAB 163,15,2001
|
oral | rat
lowest published toxic dose: 22.5 gm/kg (11-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Other postnatal measures or effects
NETEEC 24,719,2002
|
oral | rat
lowest published toxic dose: 40 gm/kg (1-20 day pregnant)
|
Reproductive: Other developmental abnormalities | Reproductive: Specific developmental abnormalities: Central nervous system
FATOAO 45,68,1982
|
oral | rat
lowest published toxic dose: 42 gm/kg (1-21 day pregnant)
|
Reproductive: Other developmental abnormalities
|
FATOAO 45,66,1982
|
oral | rat
lowest published toxic dose: 240 gm/kg (30 day male)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
FATOAO 47,82,1984
|
oral | rat
lowest published toxic dose: 65 gm/kg (7-19 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
ENDOAO 138,389,1997
|
oral | rat
lowest published toxic dose: 75 gm/kg (7-21 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
ENDOAO 138,389,1997
|
oral | rat
lowest published toxic dose: 112 mg/kg (14 day male)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
FATOAO 48,86,1985
|
oral | rat
lowest published toxic dose: 147 mg/kg (1-21 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Effects on newborn: Delayed effects
FATOAO 47,84,1984
|
oral | rat
lowest published toxic dose: 60,000 mg/kg (1-30 day after birth)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Effects on newborn: Biochemical and metabolic Reproductive: Effects on newborn: Delayed effects
FATOAO 48,93,1985
|
oral | rat
lowest published toxic dose: 900 mL/kg (19 day prior to copulation-21 day after birth)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Biochemical and metabolic
NETEEC 24,275,2002
|
oral | rat
lowest published toxic dose: 110 gm/kg (1-23 day pregnant)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Physical
EKFAE9 59,44,1996
|
oral | rat
lowest published toxic dose: 135 gm/kg (1 day pregnant-7 day after birth)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Physical
EKFAE9 59,44,1996
|
oral | rat
lowest published toxic dose: 210 gm/kg (6-20 day pregnant)
|
Reproductive: Effects on fertility: Abortion | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TOXID9 72(Suppl 1),341,2003
|
oral | rat
lowest published toxic dose: 90 mg/kg (30 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Other effects on male Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
LIFSAK 71,3059,2002
|
oral | rat
lowest published toxic dose: 30 gm/kg (16-20 day pregnant)
|
Reproductive: Effects on newborn: Other postnatal measures or effects
|
NETEEC 25,447,2003
|
oral | rat
lowest published toxic dose: 120 gm/kg (1-20 day pregnant)
|
Reproductive: Effects on newborn: Other postnatal measures or effects
|
NETEEC 25,447,2003
|
oral | rat
lowest published toxic dose: 45 gm/kg (15-22 day pregnant/7 day after birth)
|
Reproductive: Effects on newborn: Behavioral
|
NEROEW 24,691,2001
|
oral | rat
lowest published toxic dose: 45 gm/kg (15-22 day pregnant/7 day after birth)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Other postnatal measures or effects
NEROEW 26,191,2002
|
oral | rat
lowest published toxic dose: 10,400 mg/kg (7-19 day pregnant)
|
Reproductive: Tumorigenic effects: Transplacental tumorigenesis | Reproductive: Effects on newborn: Delayed effects
BJCAAI 90,2225,2004
|
oral | rat
lowest published toxic dose: 110 gm/kg (10-20 day pregnant)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive: Effects on newborn: Biochemical and metabolic
NETEEC 27,73,2005
|
oral | rat
lowest published toxic dose: 120 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TOXID9 44,57,2005
|
oral | rat
lowest published toxic dose: 16.25 gm/kg (7-19 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Other reproductive system tumors Reproductive: Effects on newborn: Biochemical and metabolic
BJCAAI 90,2225,2004
|
oral | rat
lowest published toxic dose: 54 gm/kg (6-14 day pregnant)
|
Reproductive: Other effects on female
|
TOXID9 78,280,2004
|
oral | rat
lowest published toxic dose: 36.5 gm/kg (30 day prior to copulation-21 day after birth)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on newborn: Behavioral
NETEEC 27,585,2005
|
oral | rat
lowest published toxic dose: 292 gm/kg (30 day prior to copulation-21 day after birth)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on newborn: Biochemical and metabolic Reproductive: Effects on newborn: Behavioral
NETEEC 27,585,2005
|
oral | rat
lowest published toxic dose: 94,500 mg/kg (1-21 day pregnant)
|
Reproductive: Effects on newborn: Stillbirth | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Behavioral
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 94,500 mg/kg (1-21 day pregnant)
|
Reproductive: Effects on newborn: Physical | Reproductive: Effects on newborn: Other postnatal measures or effects
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 99,000 mg/kg (multigeneration)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
NETEEC 28,238,2006
|
oral | rat
lowest published toxic dose: 1,188 gm/kg (55 day male)
|
Reproductive: Paternal effects: Impotence | Reproductive: Other effects on male Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
REPTED 22,599,2006
|
oral | rat
lowest published toxic dose: 1,188 gm/kg (55 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
REPTED 22,599,2006
|
oral | rat
lowest published toxic dose: 21 gm/kg (8-14 day pregnant)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Other postnatal measures or effects Reproductive: Effects on newborn: Delayed effects
ALCOH* 6,353,1989
|
oral | rabbit
lowest published toxic dose: 3,945 mg/kg (1 day prior to copulation)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated)
|
JOENAK 34,275,1966
|
oral | rabbit
lowest published toxic dose: 3,750 mg/kg (1 day prior to copulation)
|
Reproductive: Effects on fertility: Other measures of fertility
|
IJMRAQ 58,501,1970
|
oral | woman
lowest published toxic dose: 41 gm/kg (41 week pregnant)
|
Reproductive: Effects on newborn: Apgar score (human only) | Reproductive: Effects on newborn: Other neonatal measures or effects Reproductive: Effects on newborn: Drug dependence
AJDCAI 129,1075,1975
|
oral | woman
lowest published toxic dose: 250 mg/kg (37 week pregnant)
|
Reproductive: Other effects to embryo or fetus
|
AJOGAH 145,251,1983
|
oral | woman
lowest published toxic dose: 5,860 mL/kg (3 year prior to copulation-100 day after birth)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Effects on newborn: Behavioral Reproductive: Effects on newborn: Delayed effects
INJPD2 37,129,2005
|
unreported route | rat
lowest published toxic dose: 60 gm/kg (9-14 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death
FATOAO 45(1),83,1982
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 320 mg/kg/50 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Blood: Lymphoma including Hodgkin's disease
CALEDQ 13,345,1981
|
oral | mouse
toxic dose : 400 gm/kg/57 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors
ZIETA2 59,203,1928
|
rectal | mouse
lowest published toxic dose: 120 gm/kg/18 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Gastrointestinal: Tumors Liver: Tumors
ZIETA2 59,203,1928
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraarterial | man
lowest published toxic dose: 0.71 mL/kg
|
Vascular: Acute arterial occulsion
|
JKMSEH 18,585,2003
|
intraarterial | rat
lethal dose (50 percent kill): 11 mg/kg
|
Lung, Thorax, or Respiration: Chronic pulmonary edema or congestion | Lung, Thorax, or Respiration: Dyspnea
TXAPA9 18,60,1971
|
intracerebral | rat
lowest published toxic dose: 363.6 µg/kg
|
Behavioral: Alteration of operant conditioning
|
PSCHDL 170,51,2003
|
intracerebral | rat
lowest published toxic dose: 106 µg/kg
|
Behavioral: Change in motor activity (specific assay)
|
PSCHDL 170,368,2003
|
inhalation | guinea pig
lowest published lethal concentration: 21,900 ppm
|
N/R
|
FAONAU 48A,99,1970
|
inhalation | guinea pig
lowest published toxic concentration: 12,000 mg/m3/8 hour
|
Behavioral: General anesthetic
|
VCVGK* -,93,1984
|
inhalation | human
lowest published toxic concentration: 2,500 mg/m3/20 minute
|
Peripheral Nerve and Sensation: Recording from afferent nerve
|
VCVGK* -,93,1984
|
inhalation | mouse
lethal concentration (50 percent kill): 39 gm/m3/4 hour
|
N/R
|
GTPZAB 26(8),53,1982
|
inhalation | mouse
lowest published lethal concentration: 117,000 mg/m3/2 hour
|
N/R
|
VCVGK* -,93,1984
|
inhalation | mouse
lowest published toxic concentration: 50,000 mg/m3/2 hour
|
Behavioral: Alteration of classical conditioning
|
VCVGK* -,93,1984
|
inhalation | mouse
lowest published toxic concentration: 2,500 mg/m3/40 minute
|
Brain and Coverings: Other degenerative changes
|
VCVGK* -,93,1984
|
inhalation | rat
lethal concentration (50 percent kill): 20,000 ppm/10 hour
|
N/R
|
NPIRI* 1,44,1974
|
inhalation | rat
lowest published toxic concentration: 12,000 mg/m3/8 hour
|
Behavioral: General anesthetic
|
VCVGK* -,93,1984
|
inhalation | rat
lowest published toxic concentration: 4,930 mg/m3
|
N/R
|
TPKVAL 15,76,1979
|
inhalation | rat
lowest published toxic concentration: 1,110 mg/m3/4 hour
|
N/R
|
TPKVAL 15,76,1979
|
inhalation | rabbit
lowest published toxic concentration: 2,500 mg/m3/40 minute
|
Brain and Coverings: Other degenerative changes
|
VCVGK* -,93,1984
|
intramuscular | non-mammalian species
lowest published toxic dose: 0.1 gm/kg
|
Cardiac: Other changes | Musculoskeletal: Other changes
MUREAV 542,1,2003
|
intraperitoneal | dog
lowest published lethal dose: 3 gm/kg
|
N/R
|
BJIMAG 1,207,1944
|
intraperitoneal | guinea pig
lethal dose (50 percent kill): 3,414 mg/kg
|
N/R
|
EVHPAZ 61,321,1985
|
intraperitoneal | hamster
lethal dose (50 percent kill): 5,068 mg/kg
|
N/R
|
EVHPAZ 61,321,1985
|
intraperitoneal | mammal (species unspecified)
lethal dose (50 percent kill): 4,300 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold Behavioral: Change in motor activity (specific assay)
TXAPA9 13,358,1968
|
intraperitoneal | mouse
lethal dose (50 percent kill): 528 mg/kg
|
N/R
|
STRAAA 127,245,1965
|
intraperitoneal | mouse
lowest published toxic dose: 4.2 gm/kg
|
Nutritional and Gross Metabolic: Body temperature decrease
|
JPETAB 293,188,2000
|
intraperitoneal | mouse
lowest published toxic dose: 1.75 gm/kg
|
Behavioral: Ataxia
|
PSCHDL 153,415,2001
|
intraperitoneal | mouse
lowest published toxic dose: 0.5 gm/kg
|
Behavioral: Change in motor activity (specific assay)
|
NNAPBA 367,414,2003
|
intraperitoneal | mouse
lowest published toxic dose: 4.25 gm/kg
|
Behavioral: Sleep
|
PSCHDL 174,283,2004
|
intraperitoneal | mouse
lowest published toxic dose: 2 mg/kg
|
Brain and Coverings: Recordings from specific areas of CNS
|
TOLED5 145,69,2003
|
intraperitoneal | mouse
lowest published lethal dose: 4,000 mg/kg
|
Behavioral: Alteration of classical conditioning | Nutritional and Gross Metabolic: Body temperature decrease
EJPHAZ 499,285,2004
|
intraperitoneal | mouse
lowest published toxic dose: 1.5 mg/kg
|
Behavioral: Antianxiety
|
PSCHDL 177,84,2004
|
intraperitoneal | mouse
lowest published toxic dose: 2 gm/kg
|
Behavioral: Alteration of operant conditioning | Behavioral: Change in psychophysiological tests
PSCHDL 176,166,2004
|
intraperitoneal | mouse
lowest published toxic dose: 2.5 gm/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Alteration of operant conditioning Behavioral: Change in psychophysiological tests
PSCHDL 176,166,2004
|
intraperitoneal | mouse
lowest published toxic dose: 4 gm/kg
|
Behavioral: Somnolence (general depressed activity)
|
PSCHDL 174,358,2004
|
intraperitoneal | mouse
lowest published toxic dose: 2 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of classical conditioning
PSCHDL 174,291,2004
|
intraperitoneal | mouse
lowest published toxic dose: 1 gm/kg
|
Behavioral: Antianxiety | Behavioral: Change in psychophysiological tests
HOBEAO 49,123,2006
|
intraperitoneal | mouse
lowest published toxic dose: 1,000 mg/kg
|
Liver: Other changes
|
MUREAV 577S,1,2005
|
intraperitoneal | mouse
lowest published toxic dose: 0.25 gm/kg
|
Behavioral: Analgesia
|
JPETAB 309,86,2004
|
intraperitoneal | mouse
lowest published toxic dose: 2 gm/kg
|
Behavioral: Change in psychophysiological tests
|
JPETAB 314,675,2005
|
intraperitoneal | mouse
lowest published toxic dose: 4 gm/kg
|
Behavioral: Withdrawal
|
JPETAB 319,219,2006
|
intraperitoneal | mouse
lowest published toxic dose: 2.0 gm/kg
|
Behavioral: Ataxia | Nutritional and Gross Metabolic: Body temperature decrease
JPETAB 319,219,2006
|
intraperitoneal | mouse
lowest published toxic dose: 1.5 gm/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Antianxiety
PSCHDL 191,311,2007
|
intraperitoneal | mouse
lowest published toxic dose: 2 gm/kg
|
Behavioral: Ataxia | Behavioral: Alteration of classical conditioning
PSCHDL 191,311,2007
|
intraperitoneal | mouse
lowest published toxic dose: 2 gm/kg
|
Behavioral: Alteration of classical conditioning
|
PSCHDL 191,311,2007
|
intraperitoneal | mouse
lowest published toxic dose: 3.5 gm/kg
|
Behavioral: Altered sleep time (including change in righting reflex)
|
PSCHDL 191,311,2007
|
intraperitoneal | mouse
lowest published toxic dose: 0.3 mg/kg
|
Behavioral: Alteration of operant conditioning
|
PSCHDL 192,39,2007
|
intraperitoneal | mouse
lowest published toxic dose: 1.2 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Antianxiety Behavioral: Alteration of operant conditioning
PSCHDL 192,39,2007
|
intraperitoneal | mouse
lowest published toxic dose: 1.8 mg/kg
|
Behavioral: Alteration of classical conditioning | Behavioral: Antianxiety Behavioral: Alteration of operant conditioning
PSCHDL 192,39,2007
|
intraperitoneal | rat
lethal dose (50 percent kill): 3,600 µg/kg
|
N/R
|
PHMGBN 2,27,1969
|
intraperitoneal | rat
lowest published toxic dose: 2.45 gm/kg
|
Behavioral: Altered sleep time (including change in righting reflex)
|
JPETAB 299,698,2001
|
intraperitoneal | rat
lowest published toxic dose: 3,500 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
|
FATOAO 51,92,1988
|
intraperitoneal | rat
lowest published toxic dose: 1,000 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
EKFAE9 59,38,1996
|
intraperitoneal | rat
lowest published toxic dose: 0.5 gm/kg
|
Behavioral: Change in psychophysiological tests
|
EJPHAZ 462,115,2003
|
intraperitoneal | rat
lowest published toxic dose: 3,000 mg/kg
|
Behavioral: Sleep
|
TOSCF2 73,270,2003
|
intraperitoneal | rat
lowest published toxic dose: 2 gm/kg
|
Brain and Coverings: Other degenerative changes | Endocrine: Differential effect of sex or castration on observed toxicity Biochemical: Metabolism (intermediary): Other
EJPHAZ 484,241,2004
|
intraperitoneal | rat
lowest published toxic dose: 1 gm/kg
|
Taste: Change in function
|
PSCHDL 167,130,2003
|
intraperitoneal | rat
lowest published toxic dose: 2.4 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites
PSCHDL 169,60,2003
|
intraperitoneal | rat
lowest published toxic dose: 1.5 gm/kg
|
Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
|
NEROEW 28,939,2003
|
intraperitoneal | rat
lowest published toxic dose: 1.25 mg/kg
|
Behavioral: Change in motor activity (specific assay)
|
NEROEW 28,2124,2003
|
intraperitoneal | rat
lowest published toxic dose: 2,700 mg/kg
|
Behavioral: Ataxia
|
PSCHDL 170,343,2003
|
intraperitoneal | rat
lowest published toxic dose: 500 mg/kg
|
Behavioral: Analgesia
|
PSCHDL 171,204,2004
|
intraperitoneal | rat
lowest published toxic dose: 0.25 gm/kg
|
Behavioral: Alteration of operant conditioning
|
JOPSEQ 17,293,2003
|
intraperitoneal | rat
lowest published toxic dose: 0.5 gm/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of operant conditioning
JOPSEQ 17,293,2003
|
intraperitoneal | rat
lowest published toxic dose: 1,000 mg/kg
|
Behavioral: Food intake (animal)
|
EJPHAZ 519,96,2005
|
intraperitoneal | rat
lowest published toxic dose: 2,000 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other
EJPHAZ 520,51,2005
|
intraperitoneal | rat
lowest published toxic dose: 2 gm/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphokinase
JPETAB 319,1366,2006
|
intraperitoneal | rat
lowest published toxic dose: 1,000 mg/kg
|
Behavioral: Muscle weakness
|
NRTXDN 27,1064,2006
|
intraperitoneal | rat
lowest published toxic dose: 2,000 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Ataxia Behavioral: Alteration of operant conditioning
NRTXDN 27,1064,2006
|
intraperitoneal | rat
lowest published toxic dose: 500 mg/kg
|
Behavioral: Alteration of classical conditioning
|
NETEEC 29,23,2007
|
intraperitoneal | rat
lowest published toxic dose: 3,000 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Amino acids (including renal excretion)
TOLED5 169,253,2007
|
intraperitoneal | rat
lowest published toxic dose: 2 gm/kg
|
Brain and Coverings: Recordings from specific areas of CNS | Behavioral: Anticonvulsant
JPHPH* 58,641,2007
|
intraperitoneal | rat
lowest published toxic dose: 1.2 gm/kg
|
Nutritional and Gross Metabolic: Body temperature decrease
|
BJMRDK 40,1517,2007
|
intraperitoneal | rat
lowest published toxic dose: 2 gm/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
FCTOD7 46,1739,2008
|
intraperitoneal | rabbit
lethal dose (50 percent kill): 963 mg/kg
|
N/R
|
EVHPAZ 61,321,1985
|
intravenous | cat
lowest published lethal dose: 3,945 mg/kg
|
N/R
|
HBTXAC 1,130,1955
|
intravenous | chicken
lowest published lethal dose: 8,216 mg/kg
|
Vascular: Other changes
|
JPETAB 60,312,1937
|
intravenous | dog
lowest published lethal dose: 1,600 mg/kg
|
Behavioral: Ataxia | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Hypermotility, diarrhea
TXAPA9 18,60,1971
|
intravenous | human
lowest published toxic dose: 1.6 gm/kg/6 hour
|
Biochemical: Metabolism (intermediary): Other
|
CLPTAT 67,591,2000
|
intravenous | human
lowest published toxic dose: 0.89 mL/kg
|
Vascular: Regional or general arteriolar constriction | Vascular: Measurement of regional blood flow
JKMSEH 19,51,2004
|
intravenous | man
lowest published toxic dose: 0.57 gm/kg
|
Behavioral: Change in psychophysiological tests
|
NEROEW 29,1527,2004
|
intravenous | man
lowest published toxic dose: 0.571 gm/kg
|
Brain and Coverings: Other degenerative changes
|
PSCHDL 191,975,2007
|
intravenous | mouse
lowest published toxic dose: 3 gm/kg
|
Behavioral: Sleep
|
JPETAB 302,257,2002
|
intravenous | mouse
lowest published toxic dose: 3 gm/kg
|
Behavioral: Sleep | Behavioral: Tolerance
JPETAB 302,257,2002
|
intravenous | mouse
lethal dose (50 percent kill): 1,973 mg/kg
|
N/R
|
ENTOX* ,706,2005
|
intravenous | rat
lethal dose (50 percent kill): 1,440 mg/kg
|
Lung, Thorax, or Respiration: Dyspnea
|
TXAPA9 18,60,1971
|
intravenous | rat
lowest published toxic dose: 0.5 gm/kg
|
Brain and Coverings: Recordings from specific areas of CNS
|
NEROEW 29,530,2004
|
intravenous | rabbit
lethal dose (50 percent kill): 2,374 mg/kg
|
N/R
|
EVHPAZ 61,321,1985
|
intravenous | rabbit
lowest published toxic dose: 0.8 gm/kg
|
Brain and Coverings: Changes in surface EEG
|
PHREP* 57,61,2005
|
intravenous | rabbit
lowest published toxic dose: 0.8 gm/kg
|
Brain and Coverings: Changes in surface EEG | Behavioral: Ataxia
PHREP* 58,890,2006
|
multiple | man
lowest published toxic dose: 3,660 mg/kg
|
Endocrine: Evidence of thyroid hypofunction
|
PSCHDL 170,213,2003
|
oral | cat
lowest published lethal dose: 6 gm/kg
|
Gastrointestinal: Gastritis | Liver: Hepatitis (hepatocellular necrosis), diffuse Kidney, Ureter, and Bladder: Interstitial nephritis
JPETAB 56,117,1936
|
oral | child
lowest published lethal dose: 2 gm/kg
|
Lung, Thorax, or Respiration: Other changes | Liver: Fatty liver degeneration Blood: Other changes
ATXKA8 17,183,1958
|
oral | child
lowest published toxic dose: 14,400 mg/kg/30 minute- intermittent
|
Behavioral: Coma | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Nausea or vomiting
APSVAM 74,977,1985
|
oral | dog
lowest published lethal dose: 5,500 mg/kg
|
N/R
|
HBTXAC 1,130,1955
|
oral | dog
lowest published toxic dose: 2 gm/kg
|
Behavioral: Change in psychophysiological tests
|
TOXID9 66,263,2002
|
oral | guinea pig
lethal dose (50 percent kill): 5,560 mg/kg
|
N/R
|
JIHTAB 23,259,1941
|
oral | human
lowest published lethal dose: 1,400 mg/kg
|
Behavioral: Sleep | Behavioral: Headache Gastrointestinal: Nausea or vomiting
NPIRI* 1,44,1974
|
oral | human
lowest published toxic dose: 0.5 gm/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Change in psychophysiological tests
NEROEW 28,371,2003
|
oral | human
lowest published toxic dose: 1.4 gm/kg
|
Behavioral: Euphoria | Behavioral: Change in psychophysiological tests Gastrointestinal: Nausea or vomiting
NEROEW 28,740,2003
|
oral | human
lowest published toxic dose: 400 mg/kg
|
Behavioral: Alteration of operant conditioning
|
PSCHDL 172,68,2004
|
oral | human
lowest published toxic dose: 0.5 mg/kg
|
Behavioral: Change in psychophysiological tests
|
JOPSEQ 17,379,2003
|
oral | human
lowest published toxic dose: 0.7 gm/kg/10 minute
|
Behavioral: Change in psychophysiological tests
|
JOPSEQ 19,627,2005
|
oral | human
lowest published toxic dose: 600 mg/kg
|
Cardiac: Change in rate | Vascular: BP lowering not characterized in autonomic section Lung, Thorax, or Respiration: Other changes
JTCTDW 42,761,2004
|
oral | human
lowest published toxic dose: 0.1 gm/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
|
NSAPCC 369(Suppl 1),R106,2004
|
oral | infant
lowest published toxic dose: 11,712 µL/kg
|
Behavioral: General anesthetic | Cardiac: Arrythmias (indlucing changes in conduction) Lung, Thorax, or Respiration: Dyspnea
JOUOD4 9,53,1987
|
oral | mammal (species unspecified)
lowest published toxic dose: 4,000 mg/kg
|
Endocrine: Other changes | Immunological Including Allergic: Decrease in humoral immune response
TOXID9 44,184,2005
|
oral | man
lowest published toxic dose: 22,500 mg/kg/4 week- intermittent
|
Endocrine: Other changes | Blood: Other changes
CLECAP 25,143,1986
|
oral | man
lowest published toxic dose: 3,371 µL/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Behavioral: Excitement Behavioral: Coma
VHTODE 21,272,1979
|
oral | man
lowest published toxic dose: 50 mg/kg
|
Gastrointestinal: Alteration in gastric secretion | Gastrointestinal: Other changes
JPETAB 56,117,1936
|
oral | man
lowest published toxic dose: 1,430 µg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Ataxia Behavioral: Antipsychotic
JPETAB 197,488,1976
|
oral | man
lowest published toxic dose: 0.8 gm/kg
|
Behavioral: Euphoria | Behavioral: Somnolence (general depressed activity) Behavioral: Change in psychophysiological tests
JPETAB 300,236,2002
|
oral | man
lowest published toxic dose: 0.5 gm/kg
|
Cardiac: Pulse rate increased without fall in BP | Vascular: BP elevation not characterized in autonomic section Endocrine: Other changes
NEROEW 25,537,2001
|
oral | man
lowest published toxic dose: 0.8 gm/kg
|
Brain and Coverings: Changes in surface EEG | Behavioral: Change in psychophysiological tests
NEROEW 28,747,2003
|
oral | man
lowest published toxic dose: 1.14 mL/kg
|
Behavioral: Change in psychophysiological tests
|
NEROEW 28,1366,2003
|
oral | man
lowest published toxic dose: 0.6 gm/kg
|
Behavioral: Change in psychophysiological tests | Endocrine: Other changes
NEROEW 29,1156,2004
|
oral | man
lowest published toxic dose: 625 mg/kg
|
Cardiac: Pulse rate decreased with fall in BP | Cardiac: Change in rate Nutritional and Gross Metabolic: Body temperature increase
ECPPH* 2,53,1994
|
oral | man
lowest published toxic dose: 650 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Ataxia Behavioral: Alteration of operant conditioning
NRTXDN 27,1064,2006
|
oral | man
lowest published toxic dose: 0.45 gm/kg
|
Behavioral: Change in psychophysiological tests
|
ALCOH* 4,293,1987
|
oral | monkey
lowest published toxic dose: 4.8 mg/kg
|
Behavioral: Abuse
|
JPETAB 301,993,2002
|
oral | monkey
lowest published toxic dose: 102 mg/kg
|
Behavioral: Alteration of operant conditioning
|
PSCHDL 170,1,2003
|
oral | mouse
lethal dose (50 percent kill): 3,450 mg/kg
|
N/R
|
GISAAA 32(3),31,1967
|
oral | mouse
lowest published toxic dose: 5 gm/kg
|
Brain and Coverings: Other degenerative changes | Vascular: Other changes Liver: Other changes
JPETAB 298,737,2001
|
oral | mouse
lowest published toxic dose: 5 gm/kg
|
Blood: Other changes
|
TOXID9 72,99,2003
|
oral | mouse
lowest published toxic dose: 5 gm/kg
|
Liver: Changes in liver weight
|
TOXID9 72,98,2003
|
oral | mouse
lowest published toxic dose: 1 gm/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Aggression
PSCHDL 157,131,2001
|
oral | mouse
lowest published toxic dose: 6 gm/kg
|
Liver: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
TOXID9 72,202,2003
|
oral | mouse
lowest published toxic dose: 4 gm/kg
|
Endocrine: Other changes | Blood: Changes in spleen Immunological Including Allergic: Decrease in cellular immune response
TOXID9 72,172,2003
|
oral | mouse
lowest published toxic dose: 1,000 mg/kg
|
Behavioral: Aggression
|
PSCHDL 172,255,2004
|
oral | mouse
lowest published toxic dose: 5,000 mg/kg
|
Endocrine: Other changes | Blood: Changes in other cell count (unspecified)
TOXID9 44,184,2005
|
oral | mouse
lowest published toxic dose: 6,000 mg/kg
|
Blood: Changes in spleen
|
TOXID9 44,184,2005
|
oral | mouse
lowest published toxic dose: 5,000 mg/kg
|
Liver: Other changes
|
TOXID9 44,213,2005
|
oral | mouse
lowest published toxic dose: 6,000 mg/kg
|
Immunological Including Allergic: Decrease in cellular immune response
|
TOXID9 60,28,2001
|
oral | mouse
lowest published toxic dose: 1.5 mg/kg
|
Behavioral: Alteration of classical conditioning
|
ACPSI* 24,1137,2003
|
oral | mouse
lowest published toxic dose: 500 mg/kg
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Other
TXAPA9 223,225,2007
|
oral | mouse
lowest published toxic dose: 6.7 mL/kg
|
Gastrointestinal: Ulceration or bleeding from stomach
|
BMCPH* 2,21,2002
|
oral | mouse
lowest published toxic dose: 3 gm/kg
|
Behavioral: Sleep
|
JPHSC* 106,361,2008
|
oral | mouse
lowest published toxic dose: 4 gm/kg
|
Immunological Including Allergic: Decreased immune response | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TOXID9 -,276,2008
|
oral | pigeon
lowest published toxic dose: 1 gm/kg
|
Behavioral: Change in psychophysiological tests
|
JPETAB 293,551,2000
|
oral | rat
lethal dose (50 percent kill): 7,060 mg/kg
|
Lung, Thorax, or Respiration: Other changes
|
TXAPA9 16,718,1970
|
oral | rat
lowest published toxic dose: 6.4 gm/kg
|
Gastrointestinal: Alteration in gastric secretion | Gastrointestinal: Ulceration or bleeding from stomach
LIFSAK 70,17,2001
|
oral | rat
lowest published toxic dose: 1,500 mg/kg
|
Behavioral: Ataxia
|
VCVGK* -,93,1984
|
oral | rat
lowest published toxic dose: 2.5 gm/kg
|
Gastrointestinal: Other changes
|
AEPPAE 365,17,2002
|
oral | rat
lowest published toxic dose: 8,000 mg/kg
|
Brain and Coverings: Other degenerative changes | Cardiac: Cardiomyopathy including infarction Liver: Multiple effects
FATOAO 50,52,1987
|
oral | rat
lowest published toxic dose: 3 gm/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
FATOAO 44,319,1981
|
oral | rat
lowest published toxic dose: 5 gm/kg
|
Behavioral: Change in motor activity (specific assay)
|
FATOAO 44,319,1981
|
oral | rat
lowest published toxic dose: 6,000 mg/kg
|
Biochemical: Metabolism (intermediary): Effect on mitochondrial function
|
FATOAO 55,18,1992
|
oral | rat
lowest published toxic dose: 4,800 mg/kg
|
Gastrointestinal: Ulceration or bleeding from stomach
|
FATOAO 51,82,1988
|
oral | rat
lowest published toxic dose: 10 mL/kg
|
Gastrointestinal: Gastritis
|
JPETAB 303,1301,2002
|
oral | rat
lowest published toxic dose: 5 mL/kg
|
Gastrointestinal: Alteration in gastric secretion | Gastrointestinal: Ulceration or bleeding from stomach
FCLPH* 16,311,2002
|
oral | rat
lowest published toxic dose: 5.25 gm/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases
TOXID9 72,128,2003
|
oral | rat
lowest published toxic dose: 1,600 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Metabolism (intermediary): Lipids including transport
FCTOD7 41,1551,2003
|
oral | rat
lowest published toxic dose: 0.5 gm/kg
|
Brain and Coverings: Other degenerative changes
|
TOLED5 133,255,2002
|
oral | rat
lowest published toxic dose: 5,250 mg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NETEEC 26,451,2004
|
oral | rat
lethal dose (50 percent kill): 7 gm/kg
|
N/R
|
USXXAM #6696575
|
oral | rat
lowest published toxic dose: 3 gm/kg
|
Liver: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
TXAPA9 197,206,2004
|
oral | rat
lowest published toxic dose: 5,000 mg/kg
|
Endocrine: Other changes | Blood: Changes in other cell count (unspecified)
TOXID9 44,184,2005
|
oral | rat
lowest published toxic dose: 5,000 mg/kg
|
Immunological Including Allergic: Decrease in cellular immune response
|
TOXID9 44,184,2005
|
oral | rat
lowest published toxic dose: 1,500 mg/kg
|
Behavioral: Alteration of classical conditioning
|
TOXID9 44,224,2005
|
oral | rat
lowest published toxic dose: 5 gm/kg
|
Behavioral: Anticonvulsant
|
ARTODN 79,610,2005
|
oral | rat
lowest published toxic dose: 0.72 gm/kg
|
Behavioral: Abuse | Endocrine: Differential effect of sex or castration on observed toxicity
BJMRDK 37,1511,2004
|
oral | rat
lowest published toxic dose: 10.5 gm/kg/2 hour
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other
TOXID9 78,380,2004
|
oral | rat
lowest published toxic dose: 6 gm/kg
|
Behavioral: Alteration of classical conditioning | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
PSCHDL 175,189,2004
|
oral | rat
lowest published toxic dose: 5,000 mg/kg
|
Behavioral: General anesthetic
|
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 6,000 mg/kg
|
Behavioral: Change in psychophysiological tests
|
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 5 mL/kg
|
Gastrointestinal: Ulceration or bleeding from stomach
|
BPBLEO 30,451,2007
|
oral | rat
lowest published toxic dose: 4 mL/kg
|
Gastrointestinal: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
BPBLEO 29,1973,2006
|
oral | rat
lowest published toxic dose: 10 mL/kg
|
Gastrointestinal: Ulceration or bleeding from stomach | Gastrointestinal: Other changes
BPBLEO 29,2206,2006
|
oral | rat
lowest published toxic dose: 10 mL/kg
|
Gastrointestinal: Other changes
|
BPBLEO 29,2206,2006
|
oral | rat
lowest published toxic dose: 4,300 mg/kg
|
Vascular: Measurement of regional blood flow
|
TXCYAC 235,141,2007
|
oral | rat
lowest published toxic dose: 6,000 mg/kg
|
Biochemical: Metabolism (intermediary): Other
|
TXCYAC 235,141,2007
|
oral | rat
lowest published toxic dose: 0.4 gm/kg
|
Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites
|
PSCHDL 191,679,2007
|
oral | rat
lowest published toxic dose: 4.44 mL/kg
|
Gastrointestinal: Ulceration or bleeding from stomach | Gastrointestinal: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
PHREP* 57,481,2005
|
oral | rabbit
lethal dose (50 percent kill): 6,300 mg/kg
|
N/R
|
HBTXAC 1,130,1955
|
oral | woman
lowest published toxic dose: 1,200 mg/kg/3 hour
|
Endocrine: Change in gonadotropins | Endocrine: Other changes Blood: Other changes
ACRSDM 7,289,1983
|
oral | woman
lowest published toxic dose: 256 gm/kg/12 week
|
Behavioral: Hallucinations, distorted perceptions | Endocrine: Effect on menstrual cycle
JAMAAP 238,2143,1977
|
oral | woman
lowest published toxic dose: 0.7 gm/kg
|
Behavioral: Change in psychophysiological tests
|
JOPSEQ 16,379,2002
|
parenteral | frog
lowest published lethal dose: 36 gm/kg
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Behavioral: Somnolence (general depressed activity)
AIPTAK 50,296,1935
|
subcutaneous | chicken
lowest published lethal dose: 5 gm/kg
|
N/R
|
FDWU** -,-,1931
|
subcutaneous | dog
lowest published lethal dose: 6 gm/kg
|
N/R
|
HBTXAC 1,130,1955
|
subcutaneous | frog
lowest published lethal dose: 7,100 mg/kg
|
N/R
|
HBTXAC 1,128,1955
|
subcutaneous | infant
lowest published lethal dose: 19,440 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Coma Nutritional and Gross Metabolic: Body temperature decrease
AJCPAI 5,466,1935
|
subcutaneous | mouse
lethal dose (50 percent kill): 8,285 mg/kg
|
N/R
|
FAONAU 48A,99,1970
|
subcutaneous | mouse
lowest published toxic dose: 5 gm/kg
|
Liver: Hepatitis (hepatocellular necrosis), zonal
|
TOXID9 66,119,2002
|
subcutaneous | pigeon
lowest published lethal dose: 5 gm/kg
|
N/R
|
FDWU** -,-,1931
|
subcutaneous | rabbit
lowest published lethal dose: 20 gm/kg
|
N/R
|
YAKUD5 22,651,1980
|
skin | rabbit
lowest published lethal dose: 20 gm/kg
|
N/R
|
31ZTAS -,72,1968
|
unreported route | mouse
lowest published lethal dose: 2 gm/kg
|
N/R
|
JTSCDR 32,421,2007
|
unreported route | rat
lowest published toxic dose: 3 gm/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other proteins
TOLED5 150,325,2004
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 8,000 mg/m3/4 hour/17 week- intermittent
|
Brain and Coverings: Other degenerative changes | Endocrine: Other changes Immunological Including Allergic: Decreased immune response
VCVGK* -,93,1994
|
inhalation | rat
lowest published toxic concentration: 8,000 mg/m3/4 hour/17 week- intermittent
|
Brain and Coverings: Other degenerative changes | Endocrine: Other changes Immunological Including Allergic: Decreased immune response
VCVGK* -,93,1994
|
inhalation | rat
lowest published toxic concentration: 6,130 ppm/4 week- intermittent
|
Endocrine: Changes in thymus weight
|
JAPTO* 25,193,2005
|
inhalation | rat
lowest published toxic concentration: 6,130 ppm/4 week- intermittent
|
Brain and Coverings: Other degenerative changes | Cardiac: Changes in heart weight Endocrine: Hyperglycemia
JAPTO* 25,193,2005
|
inhalation | rat
lowest published toxic concentration: 6,130 ppm/4 week- intermittent
|
Biochemical: Metabolism (intermediary): Other
|
JAPTO* 25,193,2005
|
inhalation | rat
lowest published toxic concentration: 4,930 mg/m3/4 day- intermittent
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve | Lung, Thorax, or Respiration: Other changes
TPKVAL 15,76,1979
|
inhalation | rat
lowest published toxic concentration: 4,930 mg/m3/8 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
TPKVAL 15,76,1979
|
inhalation | rat
lowest published toxic concentration: 4,930 mg/m3/14 day- intermittent
|
Behavioral: Change in motor activity (specific assay)
|
TPKVAL 15,76,1979
|
inhalation | rat
lowest published toxic concentration: 1,110 mg/m3/14 day- intermittent
|
Vascular: Other changes
|
TPKVAL 15,76,1979
|
inhalation | rabbit
lowest published toxic concentration: 8,000 mg/m3/4 hour/17 week- intermittent
|
Brain and Coverings: Other degenerative changes | Endocrine: Other changes Immunological Including Allergic: Decreased immune response
VCVGK* -,93,1994
|
intramuscular | mouse
lowest published toxic dose: 42 gm/kg/14 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | Liver: Other changes
FATOAO 46,103,1983
|
intramuscular | mouse
lowest published toxic dose: 63 gm/kg/21 day- intermittent
|
Liver: Fatty liver degeneration | Liver: Liver function tests impaired
FATOAO 46,103,1983
|
intramuscular | rat
lowest published toxic dose: 420 gm/kg/6 week- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Liver: Fatty liver degeneration Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
JPETAB 299,832,2001
|
intraperitoneal | mouse
lowest published toxic dose: 12 mg/kg/3 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
BJPCBM 138,9,2003
|
intraperitoneal | mouse
lowest published toxic dose: 4 gm/kg/8 day- intermittent
|
Behavioral: Alteration of classical conditioning | Behavioral: Change in psychophysiological tests
PSCHDL 176,50,2004
|
intraperitoneal | mouse
lowest published toxic dose: 37.8 mg/kg/21 day- intermittent
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Tolerance Behavioral: Alteration of classical conditioning
PSCHDL 192,39,2007
|
intraperitoneal | mouse
lowest published toxic dose: 12.6 mg/kg/21 day- intermittent
|
Behavioral: Tolerance
|
PSCHDL 192,39,2007
|
intraperitoneal | rat
lowest published toxic dose: 4.8 mg/kg/4 day- intermittent
|
Behavioral: Change in motor activity (specific assay)
|
PSCHDL 160,48,2002
|
intraperitoneal | rat
lowest published toxic dose: 7,000 mg/kg/7 day- intermittent
|
Behavioral: Change in psychophysiological tests | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NETEEC 29,23,2007
|
intraperitoneal | rat
lowest published toxic dose: 7,000 mg/kg/7 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
NETEEC 29,23,2007
|
intraperitoneal | rat
lowest published toxic dose: 7,000 mg/kg/7 day- intermittent
|
Behavioral: Tolerance | Behavioral: Change in psychophysiological tests
NETEEC 29,23,2007
|
intraperitoneal | rat
lowest published toxic dose: 3 gm/kg/3 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
PSCHDL 191,909,2007
|
intraperitoneal | rat
lowest published toxic dose: 14 gm/kg/19 day- intermittent
|
Behavioral: Tolerance | Nutritional and Gross Metabolic: Body temperature decrease
BJMRDK 40,1517,2007
|
intraperitoneal | rat
lowest published toxic dose: 16 gm/kg/19 day- intermittent
|
Nutritional and Gross Metabolic: Body temperature decrease
|
BJMRDK 40,1517,2007
|
oral | dog
lowest published toxic dose: 560 mL/kg/10 week- continuous
|
Brain and Coverings: Other degenerative changes | Cardiac: Other changes Liver: Other changes
PSEBAA 128,1021,1968
|
oral | guinea pig
lowest published toxic dose: 204 gm/kg/68 day- continuous
|
Reproductive: Other effects on female
|
JPETAB 308,644,2004
|
oral | hamster
lowest published toxic dose: 512 mg/kg/30 day- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
CBCPAI 129,285,2001
|
oral | hamster
lowest published toxic dose: 559 mg/kg/30 day- continuous
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
CBCPAI 129,285,2001
|
oral | human
lowest published toxic dose: 149 units/kg/4 year- intermittent
|
Skin: After systemic exposure: Dermatitis, other
|
BJDEAZ 155,195,2006
|
oral | mammal (species unspecified)
lowest published toxic dose: 112,000 mg/kg/28 day- intermittent
|
Immunological Including Allergic: Decrease in cellular immune response
|
TOXID9 44,184,2005
|
oral | man
lowest published toxic dose: 4,623 gm/kg/12 year- intermittent
|
Brain and Coverings: Other degenerative changes
|
DADEDV 65,159,2002
|
oral | monkey
lowest published toxic dose: 210 gm/kg/5 week- intermittent
|
Liver: Fatty liver degeneration
|
JTSCDR 8,243,1983
|
oral | monkey
lowest published toxic dose: 260 gm/kg/2 year- intermittent
|
Behavioral: Alteration of classical conditioning | Behavioral: Aggression
PSCHDL 165,1,2002
|
oral | monkey
lowest published toxic dose: 32.5 gm/kg/90 day- intermittent
|
Cardiac: Change in rate
|
PSCHDL 192,183,2007
|
oral | mouse
lowest published toxic dose: 3,500 gm/kg/10 week- continuous
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
|
JPETAB 225,479,1983
|
oral | mouse
lowest published toxic dose: 2,100 gm/kg/5 week- continuous
|
Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
|
JPETAB 225,479,1983
|
oral | mouse
lowest published toxic dose: 1,750 gm/kg/5 week- continuous
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
JPETAB 225,479,1983
|
oral | mouse
lowest published toxic dose: 448 gm/kg/4 week- continuous
|
Behavioral: Fluid intake
|
NTIS** #PB85118651
|
oral | mouse
lowest published toxic dose: 24,000 mL/kg/120 day- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition
|
TOXID9 72,195,2003
|
oral | mouse
lowest published toxic dose: 36,000 mL/kg/180 day- continuous
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOXID9 72,195,2003
|
oral | mouse
lowest published toxic dose: 36,000 mL/kg/180 day- continuous
|
Liver: Other changes | Nutritional and Gross Metabolic: Changes in: Fe Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOXID9 72,195,2003
|
oral | mouse
lowest published toxic dose: 1,120 gm/kg/4 week- intermittent
|
Blood: Changes in spleen | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOSCF2 73,72,2003
|
oral | mouse
lowest published toxic dose: 98,800 mg/kg/13 day- continuous
|
Behavioral: Withdrawal | Behavioral: Alteration of classical conditioning
EJPHAZ 499,285,2004
|
oral | mouse
lowest published toxic dose: 480,000 mg/kg/60 day- continuous
|
Gastrointestinal: Changes in structure or function of exocrine pancreas
|
TOXID9 44,318,2005
|
oral | mouse
lowest published toxic dose: 396 gm/kg/198 day- continuous
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
TOXID9 78,14,2004
|
oral | mouse
lowest published toxic dose: 396 gm/kg/198 day- continuous
|
Liver: Other changes | Nutritional and Gross Metabolic: Changes in: Fe Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TOXID9 78,14,2004
|
oral | mouse
lowest published toxic dose: 295.2 gm/kg/10 week- intermittent
|
Cardiac: Cardiomyopathy including infarction | Cardiac: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphokinase
TOXID9 78,167,2004
|
oral | mouse
lowest published toxic dose: 15,000 mg/kg/2 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Metabolism (intermediary): Other
TOXID9 60,41,2001
|
oral | mouse
lowest published toxic dose: 35 gm/kg/5 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other proteins
TXCYAC 215,234,2005
|
oral | mouse
lowest published toxic dose: 95,200 mg/kg/4 week- intermittent
|
Behavioral: Food intake (animal) | Behavioral: Fluid intake
NTPTR* TR-510
|
oral | mouse
lowest published toxic dose: 78,400 mg/kg/4 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
NTPTR* TR-510
|
oral | mouse
lowest published toxic dose: 496,000 mg/kg/80 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NTPTR* TR-510
|
oral | mouse
lowest published toxic dose: 2,920,000 mg/kg/2 year- intermittent
|
Liver: Other changes | Liver: Tumors Liver: Changes in liver weight
NTPTR* TR-510
|
oral | mouse
lowest published toxic dose: 5,256,000 mg/kg/2 year- intermittent
|
Liver: Tumors
|
NTPTR* TR-510
|
oral | mouse
lowest published toxic dose: 470,220 mg/kg/51 day- continuous
|
Musculoskeletal: Osteoporosis
|
TXAPA9 220,302,2007
|
oral | mouse
lowest published toxic dose: 284.4 gm/kg/45 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Metabolism (intermediary): Lipids including transport
HETOEA 22,149,2003
|
oral | mouse
lowest published toxic dose: 84 gm/kg/5 week- continuous
|
Cardiac: Cardiomyopathy including infarction | Cardiac: Other changes Cardiac: Changes in heart weight
NSAPCC 375(Suppl 1),60,2007
|
oral | mouse
lowest published toxic dose: 84 gm/kg/5 week- continuous
|
Vascular: Relaxation (isolated tissue)
|
NSAPCC 375(Suppl 1),60,2007
|
oral | mouse
lowest published toxic dose: 284.4 gm/kg/45 day- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Endocrine: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
FCLPH* 20,129,2006
|
oral | mouse
lowest published toxic dose: 72 mL/kg/4 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
FCTOD7 46,1503,2008
|
oral | mouse
lowest published toxic dose: 284.4 gm/kg/45 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Effect on Na-K pump
SIMEJ* 47,864,2006
|
oral | rat
lowest published toxic dose: 1,825 gm/kg/1 year- continuous
|
Liver: Fatty liver degeneration | Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
DDSCDJ 25,587,1980
|
oral | rat
lowest published toxic dose: 19 gm/kg/21 day- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
TOLED5 12,265,1982
|
oral | rat
lowest published toxic dose: 280 gm/kg/5 week- intermittent
|
Cardiac: Changes in heart weight | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Related to Chronic Data: Changes in testicular weight
JTSCDR 8,243,1983
|
oral | rat
lowest published toxic dose: 851 gm/kg/10 week- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
APTOA6 38,260,1976
|
oral | rat
lowest published toxic dose: 7 mL/kg/7 day- intermittent
|
Liver: Other changes | Biochemical: Effect on specific coenzyme: B vitamins including folate
JDGRAX 10(1-2),25,1978
|
oral | rat
lowest published toxic dose: 6,300 mg/kg/9 week- intermittent
|
Liver: Other changes | Liver: Changes in liver weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
GISAAA 64(1),46,1999
|
oral | rat
lowest published toxic dose: 45 gm/kg/30 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
GISAAA -,64,1993
|
oral | rat
lowest published toxic dose: 62.5 gm/kg/5 day- continuous
|
Brain and Coverings: Other degenerative changes | Endocrine: Effect on menstrual cycle Endocrine: Change in gonadotropins
BIREBV 37,1089,1987
|
oral | rat
lowest published toxic dose: 62.5 gm/kg/6 day- continuous
|
Endocrine: Effect on menstrual cycle
|
BIREBV 37,1089,1987
|
oral | rat
lowest published toxic dose: 65 gm/kg/13 day- continuous
|
Endocrine: Other changes
|
ENDOAO 138,389,1997
|
oral | rat
lowest published toxic dose: 900 mL/kg/62 day- continuous
|
Behavioral: Fluid intake | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NETEEC 24,275,2002
|
oral | rat
lowest published toxic dose: 240,000 mg/kg/30 day- intermittent
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
FATOAO 47,82,1984
|
oral | rat
lowest published toxic dose: 35,000 mg/kg/7 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
EKFAE9 59,44,1996
|
oral | rat
lowest published toxic dose: 115,000 mg/kg/23 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
EKFAE9 59,44,1996
|
oral | rat
lowest published toxic dose: 67.5 mg/kg/15 day- continuous
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Xanthine, purine or nucleotides including urate Biochemical: Metabolism (intermediary): Other proteins
JPETAB 296,857,2001
|
oral | rat
lowest published toxic dose: 93.8 mL/kg/2 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
JJATDK 22,207,2002
|
oral | rat
lowest published toxic dose: 882 gm/kg/75 day- intermittent
|
Musculoskeletal: Other changes
|
JPETAB 301,1132,2002
|
oral | rat
lowest published toxic dose: 72 gm/kg/7 day- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
TOXID9 72,315,2003
|
oral | rat
lowest published toxic dose: 908 mg/kg/4 week- continuous
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
JAPTO* 22,207,2002
|
oral | rat
lowest published toxic dose: 1,372 gm/kg/20 week- continuous
|
Behavioral: Food intake (animal) | Vascular: Regional or general arteriolar constriction Vascular: Other changes
CEXPB9 29,707,2002
|
oral | rat
lowest published toxic dose: 8 mg/kg/4 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Metabolism (intermediary): Other proteins
TOXID9 72,127,2003
|
oral | rat
lowest published toxic dose: 9,660 gm/kg/56 week- intermittent
|
Cardiac: Change in resting or action potential | Endocrine: Differential effect of sex or castration on observed toxicity Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 189,196,2003
|
oral | rat
lowest published toxic dose: 240 gm/kg/60 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
TOXIA6 42,367,2003
|
oral | rat
lowest published toxic dose: 12 gm/kg/20 day- continuous
|
Behavioral: Tolerance | Behavioral: Alteration of operant conditioning
EJPHAZ 477,129,2003
|
oral | rat
lowest published toxic dose: 210 gm/kg/10 week- continuous
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Metabolism (intermediary): Lipids including transport
FCTOD7 41,1551,2003
|
oral | rat
lowest published toxic dose: 4,500 gm/kg/24 week- intermittent
|
Behavioral: Food intake (animal) | Cardiac: Change in force of contraction Endocrine: Differential effect of sex or castration on observed toxicity
TXAPA9 179,111,2002
|
oral | rat
lowest published toxic dose: 84 gm/kg/4 week- intermittent
|
Behavioral: Food intake (animal) | Endocrine: Other changes Nutritional and Gross Metabolic: Other changes
BJMRDK 36,125,2003
|
oral | rat
lowest published toxic dose: 14 gm/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
BJMRDK 36,503,2003
|
oral | rat
lowest published toxic dose: 28 gm/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Neurotransmitters or modulators (putative): Catecholamine levels in CNS Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
BJMRDK 36,503,2003
|
oral | rat
lowest published toxic dose: 875 mg/kg/10 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Effect on Na-K pump
LIFSAK 71,2881,2002
|
oral | rat
lowest published toxic dose: 41.6 gm/kg/4 day- continuous
|
Behavioral: Analgesia
|
LIFSAK 73,3351,2003
|
oral | rat
lowest published toxic dose: 130 gm/kg/10 day- continuous
|
Behavioral: Tolerance | Behavioral: Withdrawal
LIFSAK 73,3351,2003
|
oral | rat
lowest published toxic dose: 36,000 mg/kg/6 day- continuous
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of classical conditioning Behavioral: Alteration of operant conditioning
NETEEC 26,35,2004
|
oral | rat
lowest published toxic dose: 8 gm/kg/10 day- intermittent
|
Behavioral: Abuse
|
PSCHDL 168,208,2003
|
oral | rat
lowest published toxic dose: 300 gm/kg/12 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
FCTOD7 42,429,2004
|
oral | rat
lowest published toxic dose: 27,000 mg/kg/6 day- intermittent
|
Brain and Coverings: Other degenerative changes
|
NETEEC 26,353,2004
|
oral | rat
lowest published toxic dose: 31,500 mg/kg/6 day- intermittent
|
Cardiac: Change in rate
|
NETEEC 26,451,2004
|
oral | rat
lowest published toxic dose: 21,000 mg/kg/7 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
BJPCBM 138,1376,2003
|
oral | rat
lowest published toxic dose: 15 gm/kg/15 day- intermittent
|
Endocrine: Androgenic
|
REPTED 17,641,2003
|
oral | rat
lowest published toxic dose: 30 gm/kg/15 day- intermittent
|
Endocrine: Estrogenic
|
REPTED 17,641,2003
|
oral | rat
lowest published toxic dose: 90 gm/kg/15 day- intermittent
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
REPTED 17,641,2003
|
oral | rat
lowest published toxic dose: 108 gm/kg/4 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Liver: Other changes
FCTOD7 42,2045,2004
|
oral | rat
lowest published toxic dose: 10,400 mg/kg/13 day- intermittent
|
Endocrine: Estrogenic
|
BJCAAI 90,2225,2004
|
oral | rat
lowest published toxic dose: 875 gm/kg/35 day- continuous
|
Liver: Liver function tests impaired
|
TXAPA9 197,206,2004
|
oral | rat
lowest published toxic dose: 42 gm/kg/7 day- intermittent
|
Behavioral: Change in psychophysiological tests
|
NETEEC 27,55,2005
|
oral | rat
lowest published toxic dose: 25,000 mg/kg/5 day- intermittent
|
Behavioral: Alteration of operant conditioning
|
PSCHDL 171,204,2004
|
oral | rat
lowest published toxic dose: 420 gm/kg/10 week- intermittent
|
Brain and Coverings: Other degenerative changes | Musculoskeletal: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
TXCYAC 199,161,2004
|
oral | rat
lowest published toxic dose: 48,000 mg/kg/12 week- intermittent
|
Cardiac: Other changes | Vascular: BP elevation not characterized in autonomic section Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TOXID9 44,46,2005
|
oral | rat
lowest published toxic dose: 6,650 mL/kg/10 week- continuous
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
CBCPAI 131,161,2002
|
oral | rat
lowest published toxic dose: 273,000 mg/kg/21 day- continuous
|
Musculoskeletal: Osteoporosis
|
TOXID9 44,354,2005
|
oral | rat
lowest published toxic dose: 1,428,000 mg/kg/14 day- continuous
|
Behavioral: Fluid intake | Liver: Other changes Nutritional and Gross Metabolic: Conditioned vitamin deficiency
DCTODJ 26,191,2003
|
oral | rat
lowest published toxic dose: 168 gm/kg/12 week- intermittent
|
Cardiac: Other changes | Vascular: BP elevation not characterized in autonomic section Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOXID9 78,168,2004
|
oral | rat
lowest published toxic dose: 270 gm/kg/90 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Other proteins
ARTODN 78,276,2004
|
oral | rat
lowest published toxic dose: 54 gm/kg/9 day- intermittent
|
Endocrine: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Musculoskeletal: Other changes
TOXID9 78,280,2004
|
oral | rat
lowest published toxic dose: 54 gm/kg/9 day- intermittent
|
Endocrine: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Musculoskeletal: Osteoporosis
TOXID9 78,280,2004
|
oral | rat
lowest published toxic dose: 60 gm/kg/30 day- intermittent
|
Biochemical: Neurotransmitters or modulators (putative): Catecholamine levels in CNS | Biochemical: Neurotransmitters or modulators (putative): Dopamine in striatum
BJMRDK 37,1839,2004
|
oral | rat
lowest published toxic dose: 50 gm/kg/10 day- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Other
PSCHDL 182,58,2005
|
oral | rat
lowest published toxic dose: 600,000 mg/kg/75 day- intermittent
|
Musculoskeletal: Other changes | Nutritional and Gross Metabolic: Changes in: Ca
TOXID9 60,388,2001
|
oral | rat
lowest published toxic dose: 354,000 mg/kg/30 day- intermittent
|
Musculoskeletal: Other changes | Nutritional and Gross Metabolic: Changes in: Ca
TOXID9 60,388,2001
|
oral | rat
lowest published toxic dose: 462,000 mg/kg/6 week- intermittent
|
Musculoskeletal: Other changes
|
TOXID9 60,388,2001
|
oral | rat
lowest published toxic dose: 31.5 gm/kg/6 day- intermittent
|
Behavioral: Change in psychophysiological tests | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NETEEC 27,815,2005
|
oral | rat
lowest published toxic dose: 126 gm/kg/12 week- continuous
|
Vascular: BP lowering not characterized in autonomic section
|
JPETAB 306,271,2003
|
oral | rat
lowest published toxic dose: 400 gm/kg/8 week- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS | Behavioral: Withdrawal
JPETAB 307,566,2003
|
oral | rat
lowest published toxic dose: 52,800 mg/kg/6 day- intermittent
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Withdrawal Gastrointestinal: Other changes
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 52,800 mg/kg/6 day- intermittent
|
Liver: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 52,800 mg/kg/6 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
TOVEFN (5),13,2002
|
oral | rat
lowest published toxic dose: 30 gm/kg/3 day- continuous
|
Biochemical: Effect on specific coenzyme: Proportion of isoenzymes | Liver: Other changes
ACPSI* 24,831,2003
|
oral | rat
lowest published toxic dose: 195 gm/kg/30 day- continuous
|
Brain and Coverings: Other degenerative changes
|
ACPSI* 24,930,2003
|
oral | rat
lowest published toxic dose: 420,000 mg/kg/12 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes in urine composition Kidney, Ureter, and Bladder: Other changes
TXCYAC 219,11,2006
|
oral | rat
lowest published toxic dose: 210 gm/kg/6 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Liver: Changes in liver weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
BPBLEO 27,1636,2004
|
oral | rat
lowest published toxic dose: 50.4 gm/kg/7 day- continuous
|
Brain and Coverings: Other degenerative changes | Behavioral: Abuse
BJPCBM 143,455,2004
|
oral | rat
lowest published toxic dose: 300,000 mg/kg/12 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Nutritional and Gross Metabolic: Conditioned vitamin deficiency
FCTOD7 45,1478,2007
|
oral | rat
lowest published toxic dose: 216,000 mg/kg/90 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
FCTOD7 45,1333,2007
|
oral | rat
lowest published toxic dose: 315 gm/kg/9 week- intermittent
|
Vascular: BP elevation not characterized in autonomic section | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
CEXPB9 33,183,2006
|
oral | rat
lowest published toxic dose: 151.2 gm/kg/21 day- intermittent
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Change in motor activity (specific assay) Behavioral: Abuse
FCLPH* 18,693,2004
|
oral | rat
lowest published toxic dose: 980 gm/kg/14 week- intermittent
|
Behavioral: Food intake (animal) | Cardiac: Cardiac output Kidney, Ureter, and Bladder: Changes in blood vessels or in circulation of kidney
JTEHF8 68,797,2005
|
oral | rat
lowest published toxic dose: 1,050 gm/kg/70 day- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Other proteins
ALCOH* 41,591,2007
|
oral | rat
lowest published toxic dose: 188 gm/kg/25 day- intermittent
|
Liver: Fatty liver degeneration | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
INJPD2 39,43,2007
|
oral | rat
lowest published toxic dose: 140 mL/kg/2 week- continuous
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
PHREP* 58,876,2006
|
oral | rat
lowest published toxic dose: 980 gm/kg/8 week- continuous
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in kidney weight Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
FCTOD7 46,1378,2008
|
oral | rat
lowest published toxic dose: 355.5 gm/kg/45 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
SIMEJ* 48,311,2007
|
oral | rat
lowest published toxic dose: 355.5 gm/kg/45 day- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
FCTOD7 46,1627,2008
|
oral | rat
lowest published toxic dose: 1,814.4 gm/kg/12 week- continuous
|
Vascular: Measurement of regional blood flow | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases Biochemical: Metabolism (intermediary): Lipids including transport
FCTOD7 46,1940,2008
|
parenteral | rat
lowest published toxic dose: 50,000 mg/kg/50 day- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TOXID9 44,15,2005
|
subcutaneous | mouse
: 5,000 mg/kg/20 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
FCTOD7 44,588,2006
|
unreported route | mouse
lowest published toxic dose: 8 gm/kg/4 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JTSCDR 32,421,2007
|
unreported route | mouse
lowest published toxic dose: 16 gm/kg/8 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JTSCDR 32,421,2007
|
unreported route | mouse
lowest published toxic dose: 16 gm/kg/8 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JTSCDR 32,421,2007
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 1000 ppm
|
DTLVS* TLV/BEI,2007
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not classifiable as human carcinogen
|
DTLVS* TLV/BEI,2007
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 44,35,1988
|
TOXICOLOGY REVIEW
|
|
IRXPAT 11,177,1972
|
TOXICOLOGY REVIEW
|
|
AEMBAP 56,291,1975
|
TOXICOLOGY REVIEW
|
|
AICMA2 44,874,1974
|
TOXICOLOGY REVIEW
|
|
MAEPBU 6,81,1972
|
TOXICOLOGY REVIEW
|
|
FCTXAV 8,433,1970
|
TOXICOLOGY REVIEW
|
|
CLCHAU 19,361,1973
|
TOXICOLOGY REVIEW
|
|
PAREAQ 4,1,1952
|
TOXICOLOGY REVIEW
|
|
FNSCA6 2,67,1973
|
TOXICOLOGY REVIEW
|
|
SCIEAS 209,353,1980
|
TOXICOLOGY REVIEW
|
|
JAMAAP 235,1458,1976
|
TOXICOLOGY REVIEW
|
|
NEJMAG 342,186,2000
|
TOXICOLOGY REVIEW
|
|
JFSCAS 45,7,2000
|
TOXICOLOGY REVIEW
|
|
JKMSEH 17,236,2002
|
TOXICOLOGY REVIEW
|
|
TPHSDY 23,519,2002
|
TOXICOLOGY REVIEW
|
|
CRTXB2 33,407,2003
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,155,2003
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,161,2003
|
TOXICOLOGY REVIEW
|
|
PSCHDL 172,352,2004
|
TOXICOLOGY REVIEW
|
|
PBBHAU 55,501,1996
|
TOXICOLOGY REVIEW
|
|
TJADAB 21,157,1980
|
TOXICOLOGY REVIEW
|
|
TPHSDY 24,55,2003
|
TOXICOLOGY REVIEW
|
|
REPTED 22,196,2006
|
TOXICOLOGY REVIEW
|
|
TJADAB 16,53,1977
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,197,2002
|
TOXICOLOGY REVIEW
|
|
TOLED5 134,3,2002
|
TOXICOLOGY REVIEW
|
|
PSCHDL 174,539,2004
|
TOXICOLOGY REVIEW
|
|
ARPTDI 44,27,2004
|
TOXICOLOGY REVIEW
|
|
ARPTDI 44,87,2004
|
TOXICOLOGY REVIEW
|
|
REPTED 19,421,2005
|
TOXICOLOGY REVIEW
|
|
TPHSDY 24,41,2003
|
TOXICOLOGY REVIEW
|
|
TPHSDY 24,266,2003
|
TOXICOLOGY REVIEW
|
|
TPHSDY 24,151,2003
|
TOXICOLOGY REVIEW
|
|
TPHSDY 24,456,2003
|
TOXICOLOGY REVIEW
|
|
EMMUEG 45,271,2005
|
TOXICOLOGY REVIEW
|
|
JAPTO* 23,289,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 613,17,2006
|
TOXICOLOGY REVIEW
|
|
NETOX* 26,521,2005
|
TOXICOLOGY REVIEW
|
|
EJCCER 41,956,2005
|
TOXICOLOGY REVIEW
|
|
JPETAB 312,875,2005
|
TOXICOLOGY REVIEW
|
|
MUTAEX 19,251,2004
|
TOXICOLOGY REVIEW
|
|
EJPHAZ 526,113,2005
|
TOXICOLOGY REVIEW
|
|
EJPHAZ 526,163,2005
|
TOXICOLOGY REVIEW
|
|
JOPSEQ 20,143,2006
|
TOXICOLOGY REVIEW
|
|
AINCM* 7,63,2006
|
TOXICOLOGY REVIEW
|
|
BIPHEX 58,84,2004
|
TOXICOLOGY REVIEW
|
|
CHHSA* 9,6,2002
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,62,2005
|
TOXICOLOGY REVIEW
|
|
DIMON* 39,678,1993
|
TOXICOLOGY REVIEW
|
|
MUREAV 628,67,2007
|
TOXICOLOGY REVIEW
|
|
JPETAB 318,1,2006
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,742,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,263,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,387,2005
|
TOXICOLOGY REVIEW
|
|
MUREAV 584,1,2005
|
TOXICOLOGY REVIEW
|
|
NETEEC 29,425,2007
|
TOXICOLOGY REVIEW
|
|
ALCOH* 41,399,2007
|
TOXICOLOGY REVIEW
|
|
ALCOH* 41,479,2007
|
TOXICOLOGY REVIEW
|
|
MUREAV 654,114,2008
|
TOXICOLOGY REVIEW
|
|
PHREP* 57,23,2005
|
TOXICOLOGY REVIEW
|
|
MUREAV 654,114,2008
|
TOXICOLOGY REVIEW
|
|
PSBUL* 35,89,2001
|
TOXICOLOGY REVIEW
|
|
PSBUL* 35,66,2001
|
TOXICOLOGY REVIEW
|
|
PSBUL* 37,64,2003
|
TOXICOLOGY REVIEW
|
|
JTPAE7 19,111,2006
|
TOXICOLOGY REVIEW
|
|
REPTED 23,125,2007
|
TOXICOLOGY REVIEW
|
|
ITODC* -,327,2004
|
TOXICOLOGY REVIEW
|
|
HUTOX* -,493,1996
|
TOXICOLOGY REVIEW
|
|
HUTOX* -,577,1996
|
TOXICOLOGY REVIEW
|
|
HUTOX* -,623,1996
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: RED Completed
|
RBREV* -,290,1998
|
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 1000 ppm (1900 mg/m3)
|
DTLVS* 3,103,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 1000 ppm (1900 mg/m3)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 1000 ppm (1900 mg/m3)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 1000 ppm (1900 mg/m3)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 1000 ppm (1900 mg/m3)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 1000 ppm (1880 mg/m3), JUL2008
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 1000 ppm (1907 mg/m3), MAR2002
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 1000 ppm (1900 mg/m3), OCT 2002
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 1000 ppm (1900 mg/m3), short term exposure limit 1250 ppm (2400 mg/m3), JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 1000 ppm (1900 mg/m3), VLE 5000 ppm (9500), FEB2006
|
Occupational Exposure Limit - GERMANY
|
MAK 960 mg/m3 (500 mL/m3), 2005
|
Occupational Exposure Limit - HUNGARY
|
time-weighted average 1900 mg/m3, short term exposure limit 7600 mg/m3, SEP2000
|
Occupational Exposure Limit - KOREA
|
time-weighted average 1000 ppm (1900 mg/m3), 2006
|
Occupational Exposure Limit - MEXICO
|
time-weighted average 1000 ppm (1900 mg/m3), 2004
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 1000 mg/m3, 2003
|
Occupational Exposure Limit - NEW ZEALAND
|
time-weighted average 1000 ppm (1880 mg/m3), JAN2002
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 500 ppm (950 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 1000 ppm (1900 mg/m3), JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 1000 mg/m3, MAC(short term exposure limit) 3000 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 1000 mg/m3, short term exposure limit 2000 mg/m3, JUN2003
|
Occupational Exposure Limit - SWEDEN
|
time-weighted average 500 ppm (1000 mg/m3); | short term exposure limit 1000 ppm (1900 mg/m3), JUN2005
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 500 ppm (960 mg/m3),KZG- week 1000 ppm (1920 mg/m3), DEC2006
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 1000 ppm (1900 mg/m3), JAN1993
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 1000 ppm (1900 mg/m3), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 1000 ppm (1920 mg/m3), 2005
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not classifiable as human carcinogen
Occupational Exposure Limit IN SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not classifiable as human carcinogen | ||||||||||||||||||||||||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ETHYL ALCOHOL-air
|
10 hour time-weighted average 1000 ppm
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 31500; | Number of Industries 430; Total Number of Facilities 157,709; Number of Occupations 242; Total Number of Employees Exposed 2,088,926
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 31500 |
 ;Number of Industries 334; Total Number of Facilities 86,077; Number of Occupations 222; Total Number of Employees Exposed 2,069,125; Total Number of Female Employees Exposed 1,014,002 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal
|
EPA GENETOX PROGRAM 1988, Negative: Aspergillus-forward mutation; SHE-clonal assay
|
EPA GENETOX PROGRAM 1988, Negative: Cell transform.-RLV F344 rat embryo
|
EPA GENETOX PROGRAM 1988, Negative: In vitro cytogenetics-nonhuman; Mammalian micronucleus
|
EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy; Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-human lymphocytes; In vitro SCE-human
|
EPA GENETOX PROGRAM 1988, Negative: In vitro SCE-nonhuman; Sperm morphology-mouse
|
EPA GENETOX PROGRAM 1988, Negative/limited: Carcinogenicity-mouse/rat
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a topical anti-infective agent, solvent to make beverages
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Ethanol in blood, 8002
|
NIOSH Analytical Method, 1994: Alcohols I, 1400
|
NTP Carcinogenesis studies; on test (two year studies), October 2000
|
OSHA ANALYTICAL METHOD #100
|
| |||||||||||||||||
REFERENCES:
CODEN
|
|
REFERENCE
31ZTAS
|
"Alcohols: Their Chemistry, Properties and Manufacture," Monick, J.A., New York, Reinhold
Book, 1968
|
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
ACPSI*
|
Acta pharmacologica Sinica (Shanghai : Shanghai Institute of Materia Medica : Chinese Academy
of Science ; Carlton, VIC, Australia : Blackwell Publishing Asia, 2005) V.21- 2000-
|
ACRSDM
|
Alcoholism: Clinical and Experimental Research. (Williams & Wilkins Co., 428 E. Preston St.,
Baltimore, MD 21202) V.1- 1977-
|
ACYTAN
|
Acta Cytologica. (Science Printers and Pub., Inc., 2 Jacklynn Ct., St. Louis, MO 63132) V.1-
1957-
|
AEMBAP
|
Advances in Experimental Medicine and Biology. (Plenum Pub. Corp., 233 Spring St., New York,
NY 10013) V.1- 1967-
|
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AICMA2
|
Archivos del Instituto de Cardiologia de Mexico. (Instituto de Cardiologia de Mexico, Juan
Badiano No.1, 14080 Mexico City, Mexico) V.14- 1944-
|
AINCM*
|
Anaesthesia and Intensive Care Medicine (Abingdon: Medicine Pub. Co.) V.1- 2000-
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
AJCPAI
|
American Journal of Clinical Pathology. (Lippincott/Harper, Journal Fulfillment Dept., 2350
Virginia Ave., Hagerstown, MD 21740) V.1- 1931-
|
AJDCAI
|
American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610)
V.1-80(3), 1911-50; V.100- 1960-
|
AJOGAH
|
American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial
Dr., St. Louis, MO 63146) V.1- 1920-
|
AJOPAA
|
American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415,
Chicago, IL 60611) Series 3: V.1- 1918-
|
ALCOH*
|
|
ANREAK
|
Anatomical Record. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1906/08-
|
APSVAM
|
Acta Paediatrica Scandinavica. (Almqvist & Wiksell International, POB 4627, S-11691
Stockholm, Sweden) V.54-80 1965-91 For publisher information, see APAEEL
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
ARPTDI
|
Annual Review of Pharmacology and Toxicology. (Annual Reviews, Inc., POB 10139, Palo Alto, CA
94303) V.16- 1976-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ATXKA8
|
Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher
information, see ARTODN.
|
BDERB*
|
|
BDERE*
|
Birth Defects Research Part A, Clinical and molecular teratology (Hoboken, N.J. : John Wiley &
Sons) V.67- 2003-
|
BIPHEX
|
Biomedicine & Pharmacotherapy (Editions Scientifiques et Medicales Elsevier, Journals
Fulfilment Department, 23 rue Linois, F -75724 Paris Cedex 15, France OR Editions
Scientifiques et Medicales Elsevier, P.O.BOX 7247-7576, Philadelphia, PA 19170-7576,USA) V.
36- Jan.1982-)
|
BIREBV
|
Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL
61820) V.1- 1969-
|
BIZNAT
|
Biologisches Zentralblatt. (VEB Georg Thieme, Postfach 946, Leipzig DDR-7010, Ger. Dem. Rep.)
V.1- 1881-
|
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
BJDEAZ
|
British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63-
1951-
|
BJIMAG
|
British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME
04046) V.1- 1944-
|
BJMRDK
|
Brazilian Journal of Medical and Biological Research. (Associacao Brasileira de Divulgacao
Cientifica, Faculdade de Medicina de Ribeirao Preto, USP, 141000 Ribeirao Preto, SP, Brazil)
V.14- 1981-
|
BJPCBM
|
British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21
2XS, UK) V.34- 1968-
|
BMCPH*
|
BioMedCentral Pharmacology (Biomed Central Ltd) -
|
BPBLEO
|
Biological and Pharmaceutical Bulletin. (Pharmaceutical Society of Japan, 2-12-15-201 Shibuya
Shibuya-ku, Tokyo 150, Japan) V.16- 1993-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CBCPAI
|
Comparative Biochemistry and Physiology. (Elmsford, NY) V.1-37, 1960-70. For publisher
information, see CBPBB8.
|
CEXPB9
|
Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications,
(Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CGCGBR
|
Cytogenetics and Cell Genetics. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003)
V.12- 1973-
|
CHHSA*
|
Chemical Health & Safety (Orlando, FL : Published by Elsevier Inc. for the ACS Division of
Chemical Health and Safety) V.1- 1994-
|
CLCHAU
|
Clinical Chemistry (Winston-Salem, NC). (American Assoc. for Clinical Chemistry, 1725 K St.,
NW, Washington, DC 20006) V.1- 1955-
|
CLECAP
|
Clinical Endocrinology (Oxford). (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1-
1972-
|
CLPTAT
|
Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and
Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960-
|
CRTXB2
|
CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton,
FL 33431) V.1- 1971-
|
CYGEDX
|
Cytology and Genetics (English Translation). Translation of TGANAK. (Allerton Press Inc.,
150 Fifth Ave., New York, NY 10011) V.8- 1974-
|
CYTBAI
|
Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969-
|
DABBBA
|
Dissertation Abstracts International, B: The Sciences and Engineering. (University Microfilms
International, 300 N. Zeeb Rd., Ann Arbor, MI 48106) V.30- 1969-
|
DADEDV
|
Drug and Alcohol Dependence. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
DBRRDB
|
Developmental Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1981-
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DDSCDJ
|
Digestive Diseases and Sciences. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013)
V.24- 1979-
|
DEPBA5
|
Developmental Psychobiology. (John Wiley & Sons, Inc., 605 Third Ave., New York, NY 10158)
V.1- 1968-
|
DIMON*
|
Disease-a Month (Chicago : Year Book Publishers) V. 24- 1978-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
ECPPH*
|
Experimental and Clinical Psychopharmacology (Washington Dc American Psychological
Association) V.1- 1993-
|
EJCCER
|
Oral Oncology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier
Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V. 28B, No. 1- July 1992
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
EKFAE9
|
Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology.
(Mezhdunarodnaya Kniga, ul. B. Yakimanka, 39, 117049 Moscow, Russia) V.55- 1992-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENDOAO
|
Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203)
V.1- 1917-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ENTOX*
|
Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FAJOEC
|
FASEB Journal. Official Publication of the Federation of American Societies for Experimental
Biology. (Federation of American Societies for Experimental Biology, 9650 Rockville Pike,
Bethesda, MD 20814) V.1- 1987-
|
FAONAU
|
FAO Nutrition Meetings Report Series. (Rome, Italy) No.?-57, 1948-77. Discontinued.
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
FCLPH*
|
Fundamental & Clinical Pharmacology (Oxford : Blackwell Science) 2001-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
FDWU**
|
"Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L.,
Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931
|
FEPRA7
|
Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda,
MD) V.1-46, 1942-87.
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
FESTAS
|
Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282)
V.1- 1950-
|
FNSCA6
|
Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see
FSINDR.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
GNKAA5
|
Genetika (Moscow). For English translation, see SOGEBZ. (V/O Mezhdunarodnaya Kniga, 113095
Moscow, USSR) No.1- 1965-
|
GTPZAB
|
Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see
MTPEEI
|
HBTXAC
|
"Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59
|
HETOEA
|
Human & Experimental Toxicology. (Macmillan Press Ltd., Brunel Road, Houndmills, Basingstoke,
Hampshire, RG21 2XS, UK) V.9- 1990-
|
HOBEAO
|
Hormones and Behavior. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1969-
|
HUTOX*
|
|
IJEBA6
|
Indian Journal of Experimental Biology. (Publications & Information Directorate, CSIR,
Hillside Rd., New Delhi 110 012, India) V.1- 1963-
|
IJMRAQ
|
Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New
Delhi 110 029, India) V.1- 1913-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INJFA3
|
International Journal of Fertility. (Allen Press, 1041 New Hampshire, St., Lawrence, KS
66044) V.1- 1955-
|
INJPD2
|
Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221
005, India) V.1- 1968(?)-
|
IRXPAT
|
International Review of Experimental Pathology. (Academic Press, Inc., 1 E. First St.,
Duluth, MN 55802) V.1- 1962-
|
ITODC*
|
|
JAMAAP
|
JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL
60610) V.1- 1883-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JDGRAX
|
Journal of Drug Research. (National Organization for Drug Research and Control, POB 29,
Cairo, Egypt) V.2- 1969-
|
JFSCAS
|
Journal of Forensic Sciences. (American Soc. for Testing and Materials, 1916 Race St.,
Philadelphia, PA 19103) V.1- 1956-
|
JIHTAB
|
Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For
publisher information, see AEHLAU.
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JKMSEH
|
Journal of Korean Medical Science. (Korean Academy of Medical Science, C.P.O. Box 2062,
Seoul, S. Korea) V.1- 1986-
|
JOENAK
|
Journal of Endocrinology. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester,
Essex CO2 8HP, UK) V.1- 1939-
|
JOPSEQ
|
Journal of Psychopharmacology (Oxford). (Oxford University Press, Great Clarendon St., Oxford
OX2 6DP, UK) V.1- 1987-
|
JOUOD4
|
Journal of UOEH (University of Occupational and Environmental Health). (Univ. of Occupational
and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807, Japan) V.1- 1979-
|
JPDSA3
|
Journal of Pediatric Surgery. (Grune and Stratton, Inc., Journal Subscription Dept., POB
6280, Duluth, MN 55806) V.1- 1966-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
JPHPH*
|
|
JPHSC*
|
|
JRPFA4
|
Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way,
Colchester, Essex CO2 8HP, UK) V.1- 1960-
|
JSALDP
|
Journal of Studies on Alcohol. (P.O. Box 969, Piscataway, NJ 08854) V.36- 1975-
|
JTCTDW
|
Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY
10016) V.19- 1982-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
JTEHF8
|
Journal of Toxicology and Environmental Health, Part A. (Taylor & Francis, 47 Runway Rd.,
Suite G, Levittown, PA 19057) V.53- 1998-
|
JTPAE7
|
Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi-
shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988
|
JTSCDR
|
Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor,
Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976-
|
LIFSAK
|
Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8,
1962-69; V.14- 1974-
|
MAEPBU
|
Methods and Achievements in Experimental Pathology. (S. Karger AG, Postfach, CH-4009, Basel,
Switzerland) V.1- 1966-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NATUAS
|
Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869-
|
NATWAY
|
Naturwissenschaften. (Springer-Verlag, Heidelberger Platz 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.1- 1913-
|
NEJMAG
|
New England Journal of Medicine. (Massachusetts Medical Soc., 10 Shattuck St., Boston, MA
02115) V.198- 1928-
|
NELED5
|
Neuroscience Letters. (Elsevier Scientific Publishers Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
NEROEW
|
Neuropsychopharmacology. (Elsevier Science, 655 Avenue of the Americas, New York, NY 10010)
V.1- 1987-
|
NETEEC
|
Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.9- 1987-
|
NETOD7
|
Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information,
see NTOTDY.
|
NETOX*
|
NeuroToxicology (Amsterdam : Elsevier Science) V.1- 1979-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NNAPBA
|
Naunyn-Schmiedebergs Archiv fuer Pharmakologie. (Berlin, Ger.) V.264-271, 1969-71. For
publisher information, see NSAPCC.
|
NPIRI*
|
Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink
Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA
18015)
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NSAPCC
|
Naunyn-Schmiedeberg's Archives of Pharmacology. (Springer Verlag, Heidelberger, Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.272- 1972-
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
NTOTDY
|
Neurobehavioral Toxicology and Teratology. (Fayetteville, NY) V.3-8, 1981-86. For publisher
information, see NETEEC.
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
ONGZAC
|
Ontogenez (Moscow). For English translation, see SJDBA9. (V/O Mezhdunarodnaya Kniga, 113095,
Moscow, USSR) V.1- 1970-
|
PAREAQ
|
Pharmacological Reviews. (Williams & Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1-
1949-
|
PBBHAU
|
Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426,
Fayetteville, NY 13066) V.1- 1973-
|
PHMGBN
|
Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG,
Postfach CH-4009 Basel, Switzerland) V.1- 1968-
|
PHREP*
|
|
PLPSAX
|
Physiological Psychology. (Austin, TX) V.1-14, 1973-86.
|
PNASA6
|
Proceedings of the National Academy of Sciences of the United States of America. (National
Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418)
V.1- 1915-
|
PSBUL*
|
|
PSCHDL
|
Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way,
Secaucus, NJ 07094) V.47- 1976-
|
PSEBAA
|
Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1903/04-
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
RCOCB8
|
Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966,
Westbury, NY 11590) V.1- 1970-
|
RCPBDC
|
Research Communications in Psychology, Psychiatry and Behavior. (PJD Pub. Ltd., P.O. Box 966,
Westbury, NY 11590) V.1- 1976-
|
RECYAR
|
Revue Roumaine d'Embryologie et de Cytologia, Serie d'Embrologie. (Bucharest, Romania) V.1-8,
1964-71.
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
SCIEAS
|
Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC
20005) V.1- 1895-
|
SIMEJ*
|
|
STRAAA
|
Strahlentherapie. (Urban & Schwarzenberg, Postfach 202440, D-8000 Munich 2, Fed. Rep. Ger.)
V.1- 1912-
|
TERMG*
|
|
TERP2*
|
|
TERST*
|
|
TGANAK
|
Tsitologiya i Genetika. Cytology and Genetics. For English translation, see CYGEDX. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1967-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOVEFN
|
Toksikologicheskii Vestnik. (18-20 Vadkovskii per. Moscow, 101479, Russia) History Unknown
|
TOXIA6
|
Toxicon. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, UK) V.1- 1962-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TPHSDY
|
Trends in Pharmacological Sciences. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1979-
|
TPKVAL
|
Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial
Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow,
USSR) No.1- 1961-
|
TSITAQ
|
Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
UCDS**
|
Union Carbide Data Sheet. (Union Carbide Corp., 39 Old Ridgebury Rd., Danbury, CT 06817)
|
USXXAM
|
United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
VHTODE
|
Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology,
Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
|
YAKUD5
|
Gekkan Yakuji. Pharmaceuticals Monthly. (Yakugyo Jihosha, Inaoka Bldg., 2-36 Jinbo-cho,
Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1959-
|
ZIETA2
|
Zeitschrift fuer Immunitaetsforschung und Experimentelle Therapie. (Stuttgart, Fed. Rep.
Ger.) 1924-62. For publisher information, see ZIEKBA.
|
| |
